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Abstract 
 There is renewed interest in silks as a biomaterial due to their unique mechanical 
properties, highly organized structure, and diverse surface chemistry. This study investigates 
silk’s efficacy as an alternative biomaterial for bone regeneration and analyzes the role of 
adhesion and signaling factors in the process. Femoral defects in rodents were implanted with a 
series of scaffold combinations. Parameters included scaffold decoration (RGD or BMP-2) and 
hMSCs. Radiological and DEXA analyses demonstrated that scaffolds with BMP-2 and empty 
scaffolds produced the most bone ingrowth and defect bridging. 
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I. Introduction 
In 1988 there were more than 3 million musculoskeletal surgeries performed world wide 
and more than 450,000 in United States alone (Laurencin et al., 1999). Bone that has been 
damaged from degenerative disease and large bone tumors, and from massive fractures, defects 
and non-unions have presented major challenges to reconstructive surgery. Most procedures rely 
on the traditional therapies of bone grafting, although there are other techniques currently being 
explored. Orthopedic surgeons perform over 800,000 bone graft procedures annually, which 
require donor tissue obtained from either the patient or another person and implanted at the 
injury site (Laurencin et al., 1999). While these treatments have proved fairly successful, there 
are several drawbacks associated with its use. A second surgical site is required, there is a 
possibility of rejection, and the graft supply may be insufficient.  
 The problems associated with bone grafting have caused new treatments to emerge with 
promise to circumvent the limitations. Scientists have begun to look at tissue engineering to 
restore tissue function by regenerating or growing bone. Bone tissue engineering approaches 
include the use of a 3-dimensional, porous, degradable matrix. Another approach extracts the 
patient’s own bone-making cells which are grown in culture. Both of the matrices can be 
transplanted back into the patient. In order to accomplish this objective, a unique set of 
environmental conditions must be met.  These conditions include: an appropriate blood supply 
which provides access for bone making cells and nutrients and eliminates wastes; and a scaffold 
which serves as a template for new bone to be formed very similar to that during growth. 
Therefore, the scaffold design must meet specific requirements for bone formation. 
Previous studies of bone formation have included scaffold materials such as synthetic and 
natural polymers, ceramics, and composites.  However, the types of materials available today 
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remain limited.  In order to highlight the relative merits of silk-based scaffolds for bone 
formation, comparisons will be made to some of the most commonly used biomaterials for 
scaffolds today. Collagens have fewer options for engineering control of its structure and thus 
mechanical properties due to the primary sequence containing essentially one repetitive block 
(Gly-Pro-HyP). Generally, comparisons to synthetic polymers, such as families of polyesters, 
have limited control of properties and chemical diversity mainly due to the presence of only one 
or two monomers in the chain (in comparison to the 20 or so present in silk proteins). Calcium 
phosphates have been used due to their similarity to the mineral component of bone. However, 
the success has been limited because the biomaterial as a scaffold lacks bioactive behavior (being 
integrated into the tissue by the same processes present in modeling native bone). This limitation 
is due to its stability and hence extremely slow degradation rate. The rates of degradation for silk 
have the ability to be closely regulated through control of primary sequences and crystallinity. 
Matching the unique mechanical properties of native bone remains a challenge with many 
current biomaterials.  
It should be recognized that the principal scaffolds explored to date for bone replacement 
or regeneration have shown promise, some even approved by the  U.S. Food and Drug 
Administration (FDA). However, the shortcomings associated with these biomaterials have 
prompted the need to identify alternate scaffolds to overcome these limitations. Presently, there 
is no bone substitute that functionally and mechanically mimics natural autogenous bone. 
The principal goal of this project is to investigate the use of silk fibroin as an alternative 
scaffold material for the facilitation of bone regeneration. Silks offer remarkable mechanical 
properties with a very high strength and resistance to compression, are readily accepted by the 
body (biocompatible), and have a diverse range of surface chemistries for selective chemical 
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couplings (Sofia et al., 2000). Additionally, the interactions between cell signaling factors, 
human mesenchymal stem cells, and the silk proteins in relation to bone formation are explored. 
Specific peptides related to cell adhesion (RGD) and bone formation (BMP-2) will be chemically 
functionalized to the silk proteins in combinations with or without stem cells to develop a clearer 
understanding of the relationships between decoration type and cell responses. 
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II. Literature Review 
 Traditional surgical methods and current scaffold biomaterials have not yet proved ideal 
for bone regeneration. Cell-based therapies have been utilized to improve the regeneration of the 
damaged osseous region. The scaffold used is an essential component in tissue engineering and 
must meet certain compositional, architectural, and physiochemical requirements in order to 
mimic that of natural bone and influence appropriate tissue formation. Most scaffolds used today 
meet only few criteria for bone repair and therefore silk is explored as a biomaterial particularly 
due to their inherent mechanical properties. 
1. Bone Tissue Engineering 
Surgical treatments such as allografts and autografts have been used to repair bone 
defects. Autografts, which are transplants from the patient’s own bone, are considered the gold 
standard because they are able to regenerate bone without any immunological affect.  They also 
provide osteoinductive and osteoconductive properties, and are usually well incorporated into the 
graft site (Arrington et al., 1996). However, a second surgical site is required which leads to 
added discomfort and an extended recovery period. Additionally, obtaining a sufficient amount 
of bone from the patient can not only be difficult, but it can also be extremely painful.   
Allografts, on the other hand, utilize bone from others’ for bone repair.  With this 
technique, bone repair capability is not as successful. It is more expensive, increases donor site 
morbidity compared with autografts, and can be detrimental to the recipient if the transplant 
carries a disease or causes an immunological reaction (Petite, 2000).  Allogenic bone maintains 
osteoconductive properties but loses osteoinductive potential as a result of processing and 
radiation.  Although these methods have been widely used by doctors and have proved fairly 
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successful, their shortcomings have prompted the medical world to look to tissue engineering 
and a variety of biologic and synthetic scaffolds to facilitate bone formation. 
This area of research has the capacity to repair or restore living tissue by using 
biomaterials, stem cells, and growth factors alone or in combination. Therapies in bone tissue 
engineering include cell, gene, or cytokine therapy (Saito et al., 2003). In gene therapy, the gene 
that produces a particular protein is directly transferred to the cells in vivo or in vitro.  The gene 
then releases the desired protein into the injured area. This method is beneficial because it allows 
for a sustained local release of the protein which would provide a longer stimulus, maintaining 
the signals to create new bone (Saito et al., 2003). Studies have aimed to modify fibroblast cells 
in bone to generate bone morphogenetic protein-2 (BMP-2) or parathyroid hormone (PTH1-34) 
(Fang et al., 1996).   
Cell-based strategies have been researched for bone regeneration in which cells with 
osteogenic potential, derived from the bone marrow, are transplanted directly into the defect and 
differentiate into the desired lineage.  Also the incorporation of proteins or genetically 
engineered cells can be transplanted to promote regeneration through induction of osteoblast 
differentiation (Saito et al., 2003).  With this comes the need to develop matrices that will 
support the cell attachment, proliferation, differentiation, as well as deliver the bioactive factors 
and/or host cells (Saito et al., 2003).   
The scaffold design is essential in tissue engineering. The composition, architecture, and 
physiochemical properties play a prominent role in the capability of new bone tissue to form. 
The minimal requirements that a scaffolds should meet are discussed in the next section. 
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2. Bone Scaffold Requirements 
 In order to meet the challenging biological, mechanical, and degradation features of bone 
repair and regeneration, there are several requirements that scaffolds must possess. Important 
biological requirements are that the scaffold should not produce an inflammatory, immunogenic, 
or cytotoxic response in vivo (biocompatible). The construct should also resorb in a controlled 
manner consistent with the rate of new bone ingrowth and release nontoxic by-products 
following degradation (Yaszemski et al., 1996).  The degradation products should be 
biocompatible and readily metabolized or removed from the body. In addition to these 
requirements, the material must be osteoinductive, inducing differentiation into osteogenic cells. 
 Mechanical performance of a scaffold is an imperative and difficult feature to mimic due 
to the complex nature of bone. The skeleton has numerous functions, but one important function 
is its ability to bear load.  The mechanical properties of bone are unique in that they have high 
compressive and tensile strength. However, bone is capable of withstanding higher compressive 
strengths before fracture compared to tensile strength. The mechanical properties are attributed 
to its composition; a type I collagen extracellular matrix and other organic materials give tensile 
strength, while hydroxyapatite is responsible for resistance to compression. Around 30% of bone 
is composed of the organic compound collagen (90 - 95%) with the remainder being non-
collagenous proteins. The remaining 70% of bone is made up of the inorganic mineral 
hydroxyapatite. This inorganic component ([Ca3(P)4)2]3.Ca(OH)2) is predominantly crystalline, 
though may be present in amorphous forms. The mechanical properties of different bones are 
compared to some commonly used bone replacement materials in Table 1. The scaffold should 
serve as a temporary material with similar mechanical properties to that of the bone it is 
replacing. A stress-strain curve of trabecular bone is shown in Figure 1. 
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Figure 1: Stress-strain curve of trabecular bone  
Table 1: Mechanical Properties of Bone Compared to Bone Replacement Structures 
 Direction of 
Test 
Modulus of 
Elasticity 
(GPa) 
Tensile 
Strength 
(MPa) 
Compressive 
Strength 
(MPa) 
% Strain at 
Break 
Reference 
Leg Bones 
Femur 
Tibia 
Fibula 
Longitudinal  
17.2 
18.1 
18.6 
 
121 
140 
146 
 
167 
159 
123 
 
- 
- 
- 
Sujata, 2002 
 
Arm Bones Longitudinal 17.2-18.6 130-149 114-132 - Sujata, 2002 
Vertebrae Longitudinal 0.09-0.23 1.2-3.7 1.9-10 - Sujata, 2002 
*Bhat, Sujata. (2002) Biomaterials. Kluwer Academic Publishers 
 
Another crucial requirement of the scaffold is that the internal structure should 
accommodate vascularization and cells from the local environment (osteoconductivity) and guide 
deposition of bone in a way that ultimately mimics normal bone. Normal bone possesses an 
inherent capacity for self repair and regeneration due to the local environment of osteoprogenitor 
cells, osteoinductive proteins, and blood vessels (Yaszemski et al., 1996).  When bone is 
fractured, the repair and remodeling phases initiate an intricate cellular communication network 
of osteoblasts and osteoclasts. Osteoblasts synthesize an intermediate collagenous framework 
and then ossification of this matrix occurs to form new woven bone. The bone undergoes 
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sequential resorption and deposition that ultimately form the mineral and organic phases of bone 
(Yaszemski et al., 1995). The formation of an organized mineralized matrix is in the direction of 
the previous intermediate matrix as a result of the local stresses applied to it (Yaszemski et al., 
1995). It should be noted that during ossification, most of the mineral that is deposited forms by 
growth on existing crystals. There are, however, diseases and injuries that prevent this process of 
osseous self repair. The scaffold then acts as a template to guide tissue ingrowth.  
 As a result, the macrostructure of the material is an important characteristic because it 
determines the extent of vascularization and cell growth. Interconnectivity, porosity, and pore 
size are thus correlated with bone ingrowth. In general, the minimum requirement of pore size is 
100 µm in diameter depending upon implant location and cell sizes (Kim et al., 2004). Studies 
by Jones et al found that at pore sizes of 75 µm, the deposition of mineral salts was hindered. 
More mineralized tissue was observed at pore sizes >300 µm (Kim et al., 2004). An 
interconnected porous network promotes permeability of nutrients and gases to the cells and 
removes wastes by introducing a vascular supply into the scaffold.  
 The structure should be similar in size and shape to the native tissue/organ and also be 
highly porous. This brings cellular precursors to the reconstructed area and promotes their 
adhesion, migration, proliferation, and differentiation. The morphology and architecture of the 
scaffold should be reproducible and homogenous. 
 The drive to create biomaterial alternatives that conform to some of the above criteria has 
lead to the development of several scaffolds used in bone repair. Scaffolds that have been 
explored for orthopedic applications include synthetic and natural polymers, ceramics, and 
composites. Table 2 provides examples of common materials in each of these classes of 
materials that are being explored as bone graft substitutes. 
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Table 2: Bone Replacement Materials 
Classes of Materials Examples Reference 
Synthetic Polymers Polyesters: poly(lactic acid (PLA), poly(glycolic 
acid) (PGA), their copolymer poly(lactic-co-
glycolic acid) (PLGA); poly(ethylene glycol) 
(PEG); polyanydrides 
Yaszemski (1995), 
Saito (2002) 
Natural Polymers Collagen, hyaluronic acid derivatives, chitosan Xu (2004) 
Ceramics Hydroxyapatite (HA) Ca10(PO4)6OH2, tricalcium 
phosphate (TCP), biphasic calcium phosphate 
(BCP), bioactive glasses, calcium sulfate 
Yaszemski (1995), 
Bucholz (1987), 
Laurencin (1999) 
Composites HA/PLA, HA/chitosan KiKuchi (1997), 
Hockin (2005) 
 
 
3. Synthetic Bone Graft Substitutes 
Calcium phosphates (CaPs) have been used as a scaffold to guide and regenerate bone 
tissue.  CaPs are of interest as a substitute because of their similarity to the mineral component of 
bone (Bohner, 2000).  Research has also shown that CaP materials used as bone substitutes are 
biocompatible, bioactive, biodegradable and osteoconductive (Jarcho, 1981 & Rey, 1990).  The 
strong biocompatibility is directly related to its similarity in composition to bone. Natural 
hydroxyapaptite (HA) is found in 45% of the total bone mass (Laurencin et al., 1999). Calcium 
phosphate ceramics also offer a potentially limitless availability and eliminate the need for a 
second morbidity site.  Additionally, the macrostructure is similar to trabecular bone and 
provides a substantial interconnected pore system that promotes vascularization and tissue 
ingrowth (Laurencin et al., 1999). 
Currently, the major calcium phosphate ceramics include ß-tricalcium phosphate (ß-TCP) 
which is widely used in the forms of powders, granules, or blocks, and hydroxyapatite (HA), 
Ca10(PO4)6OH2, which is highly crystalline, osteoconductive and is the most stable CaP at 
neutral pH (Gauthier et al., 1999 & Bohner, 2000).  ß –TCP (3 Ca3(PO4)2) has been shown to 
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degrade faster than HA.  
 
More recently, biphasic calcium phosphate (BCP) has been employed 
to overcome HAs limited bioactivity by combining it with ß-TCP in adequate ratios, usually 60% 
HA and 40% ß-TCP (Bohner, 2000).  
Despite its osseointegration capabilities and its chemical and crystallographic similarity 
to the carbonated apatite in normal bone, CaPs brittleness and poor mechanical properties limit 
their use to non-stress applications (Xu et al., 2004).  The newly implanted ceramic lacks 
immediate structural support due to its low compressive and tensile strength. As a result, 
researchers have investigated the application of composites, CaPs mixed with polymers such as 
hydroxy-propyl-methyl-cellulose and poly-L-lactic acid, and also as coatings on metallic 
implants (Gauthier et al., 1999 & Kikuchi et al., 1997).  
Polymers provide flexibility in their design due to their composition and structure. This 
makes them an attractive material because their physical and chemical properties can be tailored 
to elicit a specific function. In addition, unlike the slow degrading ceramics that persist for 
months after implantation, polymers are biodegradable. Polymers that have been investigated in 
orthopedic applications for bone augmentation in load bearing applications are shown in Table 3. 
The effectiveness of a polymer as a scaffold in regards to bone regeneration is briefly described 
in comparison to other polymers.  
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Table 3: Properties of Selected Synthetic Biodegradable Polymers 
Polymer Advantages Disadvantages Authors 
Polyesters Extensively 
studied, adjust 
degradation rate, 
easily processed,  
Weak mechanical 
properties, can 
have toxic by-
products, bulk 
degradation 
Agrawal, 2000 
Taylor., 1994 
Polyanhydride Rapid and well 
defined surface 
erosion, surface 
erosion 
Poor mechanical 
properties 
Agrawal, 2000 
Polyorthoester Degrades by 
surface erosion 
Weak mechanical 
properties 
Agrawal, 2000 
Polycaprolactone Slower 
degradation rates 
in comparison  
Insufficient 
mechanical 
properties 
Agrawal, 2000 
Polycarbonate Less immunogenic  Toughness up to 
140ºC 
Agrawal, 2000 
Polyfumarate Mechanical 
properties similar 
to trabecular bone 
 Agrawal, 2000 
 
Polymeric scaffolds used for bone augmentation present several limitations.  It is evident 
in Table 3 that a common disadvantage of polymers is poor mechanical properties. The most 
extensively used synthetic polymers in biomedical applications are the polyesters such as poly-L-
lactic acid or poly(lactic-co-glycolic acid).  However, some polyester polymers present major 
disadvantages. They degrade fast relative to the amount of time it takes for host tissue to 
regenerate.  This is a result of their hydrophilic nature which causes them to degrade by a bulk 
degradation mechanism. Such degradation denotes mass loss, which changes the structure of ht e 
scaffolds, and ultimately leads to a collapsed template therefore eliminating the structural 
support necessary to promote normal bone regeneration. Thus the mechanical properties initially 
prescribed to the polymer early on in the degradation process are reduced. They also tend to be 
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too elastic and do not exhibit osteoconductive properties. The initial mechanical properties of 
some of the bioresorbable polymers used are shown in Table 4.  
The products of degradation have also raised concern in relation to toxicity. Although 
polymers have proved to be biocompatible, bulk degradation polymers tend to result in an acid 
burst that can result in inflammation. Studies to address these concerns were conducted by 
Taylor et al. in 1994.  PLA and PGA, along with four other polymers, were studied over 16 
weeks. Toxicity, rates of degradation, and toxicity of degradation components were determined. 
The degradation products of PGA and PLA were toxic at 10 days and 4 weeks respectively.  
 
Table 4: Mechanical Properties of Select Biodegradable Polymers 
 
Polymer (MW) Tensile 
Strength 
(MPa) 
Tensile 
Modulus 
(MPa) 
Flexural 
Modulus 
(MPa) 
Elongation 
Yield/Break 
(%) 
PGA (50,000) - - - - 
L-PLA (50,000) 28 1200 1400 3.7/6.0 
D,L-PLA (107,000) 29 1900 1950 4.0/6.0 
Polyanhydride 
Poly(CPP-  SA-
ISO) (31,000) 
Poly (SA-HAD) 
(142,000) 
 
- 
 
4 
 
- 
 
45 
 
- 
 
- 
 
 
- 
 
14/85 
Polyorthoester 
      DETOSU:t-   
CDM:1,6-HD 
(99,700) 
 
20 
 
820 
 
950 
 
 
4.1/220 
Polycaprolactone 
(44,000) 16 400 500 7.0/80 
Polycarbonate 
Poly(BPA-
imino) (105,000) 
Poly(DTH-
imino) (101,000) 
 
50 
 
40 
 
2150 
 
1630 
 
2400 
 
- 
 
3.5/4.0 
 
3.5/7.0 
* Agrawal et al., 2000 
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Composites were developed to overcome limitations of using ceramics and polymers 
independently. Ceramics are brittle and osteoconductive and polymers are flexible, 
biodegradable, and have no osteoconductivity. By combining the two with the following 
characteristics, the osseointegration and biocompatibility of the material is improved. In addition, 
the mechanical properties are improved (Kikuchi et al., 1997) 
 
4. Natural Bone Graft Substitutes 
Collagen has been utilized as a bone template scaffold because it exhibits important 
mechanical. It is additionally believed to be promising due to the fact that natural bone is 
composed of mainly type II collagen.  It is biocompatible and can be genetically manipulated for 
control purposes (Meinel et al., 2004).  However, studies show that the fast degradation rate of 
collagen prevents substantial calcification and causes the structure to collapse.  An in vitro study 
by Meinel et al. demonstrated that by four weeks of culture, calcium deposition in the collagen 
scaffold had significantly decreased. This was attributed to the degradation of the scaffold since 
there was progression between 2-4 weeks (Meinel et al., 2004). 
Today, collagen is one of the most widely used biomaterials for scaffolds. However, they 
have limited options for engineering control of structure and thus limited mechanical function. 
This is due to the primary sequence containing essentially one repetitive block (Gly-Pro-HyP) 
that is well conserved (Kaplan, 2000) 
Although the synthetic and natural bone substitutes discussed provide many important 
benefits, they still present disadvantages that keep the medical world in search of new 
alternatives. A brief overview of the advantages and disadvantages of clinical bone grafts and 
bone replacement substitutes are shown in Table 5. It is evident that the structural support and 
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mechanical integrity of scaffolds becomes a problem in bone tissue engineering. The mechanical 
properties of some of the commonly used bone replacement materials discussed above are 
presented in Table 6. 
Table 5: Comparison of Bone Graft Materials 
Graft Properties Advantages Disadvantages 
Autograft Osteogenic, 
osteoinductive, 
osteoconductive 
No host rejection, 
no disease 
transmission, 
retains viable 
osteoblasts 
Second donor-site 
morbidity, limited 
availability, costly 
Allograft Osteoconductive, 
weakly 
osteoinductive 
Greater 
availability than 
autograft, 
customized forms 
available, no 
additional 
surgical 
procedure 
Immunogenic, 
disease transfer 
risk, not 
osteogenic, 
expensive 
Ceramics 
(TCP, HA) 
Osteoconductive  Limitless 
availability, no 
additional 
surgical 
procedure, similar 
composition to 
bone 
Not osteogenic or 
osteoinductive, 
weak immediate 
mechanical 
support, difficult 
fabrication 
process, brittle 
Collagen  Favorable matrix 
to bone 
regeneration 
Minimal 
structural support, 
potentially 
immunogenic 
Demineralized 
Bone Matrix 
(DBM) 
Osteoconductive, 
osteoinductive 
Ease of use, no 
additional 
surgical site 
No structural 
support, not 
osteogenic 
Synthetic 
polymers 
 Low density, 
Easy to fabricate 
Low mechanical 
strength, not 
osteoconductive,
may cause tissue 
reaction 
Abbreviations: TCP= tricalcium phosphate, HA= hydroxyapatite *Adopted from Kaplan, 2000 
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Table 6: Mechanical Properties of common bone replacement structures 
 Modulus of 
Elasticity 
(GPa) 
Tensile 
Strength 
(MPa) 
Compressive 
Strength 
(MPa) 
% Strain at 
Break 
Reference 
HA 7-13 38-48 350-450 - Bhat, 2002 
PGA 8.4 890 - 30 Bhat, 2002 
PLA 1.2-3.0 28-50 - 2-6 Altman, 2002 
Collagen 0.0018-0.046 0.9-7.4 - 24-68 Altman, 2002 
*Bhat, Sujata. (2002) Biomaterials. Kluwer Academic Publishers 
Abbreviations: HA= hydroxyapatite, PGA=polyglycolic acid, PLA=polylactic acid with molecular 
weights ranging from 50,000-300,000, Collagen= rat tail collagen Type I extruded fibers tested after 
stretching from 0-50% 
 
 A reoccurring weakness presented in Table 5 with many of the synthetic and natural 
structures used for bone regeneration is the absence of osteogenic or osteoinductive properties. 
The mechanical integrity of the scaffolds also becomes a problem when introduced into the 
unique osseous environment (stress/strain/compression).  
It can be concluded that in order to effectively tissue engineer bone, the following 
minimum requirements should be met: 1) an appropriate 3-D, porous substrate must be used to 
ensure cell attachment, growth, and differentiation, and ECM production and to promote nutrient 
and waste exchange; 2) provide optimal mechanical properties that match and support those of 
native tissues; 3) biodegradable, biocompatible and resorbable characteristics; 4) allow for 
bioactive molecule delivery, and have a suitable surface chemistry; 5) a reproducible architecture 
to maintain homogeneity. The common matrices used in bone tissue engineering have been 
evaluated, and their shortcomings have proved that there is not an ideal bone scaffold as of yet.  
Most scaffolds reported only conform to a few of the criteria discussed. Therefore, there is a 
need for new biomaterials that are capable of inducing bone formation. To meet the challenging 
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native environment of bone as well as meet the challenging scaffold requirements, researchers 
have been exploring silks with their unique mechanical and functional properties.   
 
6.  Silk Scaffold for Bone Formation 
Silks are generally defined as spun fibrous protein polymer secretions synthesized by a 
variety of organisms including silkworms, spiders, scorpions, mites and flies. Silk fibers are 
usually spun into the air; however, some aquatic insects produce silks spun under water (Zhao et 
al., 2002).  Silks differ in composition, structure, and properties depending on the specific 
source. The mechanical properties are tailored to the specific functions of the silk. They are 
known to have a wide range of native functions such as high strength netting to entrap insects 
and the protective membranes that prevent environmental harm.   Other functions include 
reproduction as cocoon capsular structures, web construction and adhesion, and lifeline support 
(Altman et al., 2002).  The most extensively characterized silks are from silkworm, Bombyx 
mori, and from spiders, Nephila clavipes and Araneus diadematus (Altman et al., 2002).   
Fibrous proteins are characterized by a highly repetitive primary sequence which leads to 
significant homogeneity in secondary structure.  The organization of the primary structural 
components from a range of lepidopteran silk and one arachnid are shown in Figure 2. The 
primary structural sequence consists of a central repeating unit containing mostly hydrophobic 
amino acids that are interspersed with a more complex hydrophilic, amorphous region. This 
region is referred to as a “spacer” and is less than one tenth the size of the hydrophobic regions 
(Altman et al., 2002 & Bini et al., 2004). The N- and C-termini regions are non-repetitive and 
hydrophilic in nature. The sizes of these termini in a variety of silks are shown in Table 7.  
Additionally, this table summarizes other components of fibroin primary sequences. It should be 
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noted that although there is variability among silks, the organization of the components is 
similar.  
 
 
 
Figure 2: Organization of hydrophilic and hydrophobic domains in silk proteins. Shown is the heavy fibroin chain 
of B. mori, A. yamamai, heavy fibroin chain of G .mellonella, and N. madascariensis as indicated by respective 
fragments. *(Bini et al., 2004) 
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Table 7: Summary of Components of Hydrophilic and Hydrophobic Components of fibroin 
Sequences 
Hydrophilic blocks Hydrophobic blocks  
 
 
 
 
 
Sequence 
N-
term 
size 
(aa) 
C-
term 
size 
(aa) 
Size of 
hydrophilic 
spacer (no.aa) 
& 
representative 
sequence 
Ratio 
N-
term 
aa: 
spacer 
aa 
Ratio 
C-
term 
spacer 
aa: 
spacer 
aa 
Range 
(no. 
aa) 
Average 
(no. aa) 
No. of 
blocks 
Core 
Repeat 
Sequence 
Lepidoptera          
Bombyx mori 151 50 32-33, 
TGSSGRGPY 
VGGYSG 
4.7 1.5 159-
607 
425.7 12 *Shown 
below 
Bombyx 
mandarina 
151 b YEYAWSSE       
Antheraea mylitta 86 b SDFGTGS       
Antheraea pernyi 87 32        
Antheraea 
yamamai 
87 32 7, RRAGYDR 12.4 4.5 140-
340 
149.6 16  
Galleria 
mellonella 
189 60c 6-8 
EVIVIDDR 
27 9.5 75-99 89.38 13 d  
Arachnida          
Flagelliform          
Nephila clavipes 115 89 c        
Nephihla 
madascariensis 
115 89 c 26, 
TTIIEDLDITI 
DGADGPI 
3.4 4.4 260-
380 
341.5 5 d  
Major ampullata          
Nephila clavipes a 97 No spacer   19-46    
Gasteracantha 
mammosa 
a 89 No spacer       
Argiope aurantia a 82 No spacer       
Nephila 
senegalensis 
a 82 No spacer       
Latrodectus 
geometricus 
a 88 No spacer       
Araneus 
diadematus 
a 94 No spacer       
a
 N-terminal sequences of these proteins were not available. 
b 
 
C-terminal ends not available. 
c
 N- and C-terminal were obtained from two fragments of the sequence. These were G. 
mellonella, N. clavipes, and N. madascariensis 
d Sequences were incomplete. Number of blocks, average size and ranges were based on the 
fragments available 
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Table 7 cont: *Core Repeat Sequence  
 
 Bombyx mori Antheraea 
yamamai 
Galleria 
mellonella 
Nephila 
madascariensis 
Nephila 
clavipes 
Core 
Repeat 
Sequence 
(GAGAGS)5-
15, (GX)5-15, 
(X=V, I, A,), 
GAAS 
(S1-4 A11-13), 
GX1-4GGX, 
GGGX 
(X=A, S,Y,R, 
DV, W,R, D 
(S1-2A1-4)1-2 
GLGGLG, 
GXGGXG 
(X=L,I,V,P), 
GPC (X=L,Y, 
I) 
(GP(GGX)1-
4Y)n (X=Y, V, 
S, A), 
GRGGAn, 
GGXn(X=A, 
T, V, S) 
GAG(A)6-
7GGA,GGX 
GXGXX 
(X=Q,Y,L,A, 
S, R) 
*Adopted from Bini et al. 2004 
 
 
 
The secondary structure of the fibrous protein can consist of either helical, ß-sheet (chain 
axis is parallel to the fiber axis) or cross-ß-sheet (chain axis is perpendicular to the fiber axis) 
(Valluzi et al., 2002). Both the spider dragline silk from Nephila clavipes, and the silkworm silk 
B. mori, are characterized by a secondary structure of ß-pleated-sheets, as is the case for most 
silks (Valluzi et al., 2002). Polypeptide chains are extended from the ß-pleated-sheet structure in 
which the carbonyl oxygens and amide hydrogens are at near right angles to the long axis of the 
chain. The carbonyl oxygens form hydrogen bonds with the amide hydrogens on neighboring 
chains resulting in a pleated structure along the backbone of the peptide chain. There is extensive 
hydrogen bonding in silk as well as van der Waals interactions for stacked sheets due to the 
dominant amino acids such as glycine, alanine, and serine (Valluzi et al., 2002).  
Generally, spider dragline and silkworm silks are considered semicrystalline materials 
with amorphous flexible chains reinforced by strong crystals. The crystalline regions (ß –sheets) 
throughout the silk are very hydrophobic and consist of highly ordered protein crystals of alanine 
or alanine-glycine peptides (Kaplan, 1998). This gives silk a combination of stiffness and 
strength. Silk’s elastic property is a result of the disordered, loose, coil-like protein chains of 
glycine peptides which aggregate to form the amorphous regions. Less ordered alanine-rich 
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crystalline regions have also been identified and believed to connect the amorphous regions with 
the ß-sheets. The structural properties of the various silks depend on the composition and 
arrangement of these proteins. The crystalline and amorphous regions are shown in Figure 3. 
 
     *Zhao et al. (2002) 
Figure 3: Schematic organization of crystalline and amorphous regions in a silk fiber. The red and yellow blocks 
represent the crystalline and amorphous regions respectively. The black canted sheet-like structures are weakly 
oriented, yet crystalline. Not drawn to scale, in reality the glycine-rich amorphous regions compose about 70% of 
the fiber. 
 
In silkworm fiber, the ß-sheets consist of the glycine-alanine crystalline repeats. All of 
the crystalline regions in spider dragline fibers, in addition to the silkworm Antherea pernyi, are 
composed of alanine-rich sequences. The amino acid compositions of four different silk species 
are shown in Table 8. Generally, the crystalline regions are interspersed by domains of 34-40 
amino acids that make up the non-crystalline, or amorphous, regions of the protein. The 
proportions of crystalline and amorphous regions in the silk depend on the type of silk. Protein 
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crystals account for 40-50% of B. mori silk and 15% of silks produced by the major ampullate 
when hydrated (Craig et al., 2002).  
Table 8: Amino acid composition of silk fibroin and one glue protein (mol%) from four different 
species 
Amino acids B. mori fibroin B. mori sericin S.c. ricini 
fibroin 
A. pernyi 
fibroin 
A. yamamai 
fibroin 
Gly 
Ala 
Ser 
Tyr 
Asp 
Arg 
His 
Glu 
Lys 
Val 
Leu 
Ile 
Phe 
Pro 
Thr 
Met 
Cys 
Trp 
42.9 
30 
12.2 
4.8 
1.9 
0.5 
0.2 
1.4 
0.4 
2.5 
0.6 
0.6 
0.7 
0.5 
0.9 
0.1 
Trace 
- 
13.5 
5.8 
34 
3.6 
14.6 
3.1 
1.4 
6.2 
3.5 
2.9 
0.7 
0.7 
0.4 
0.6 
8.8 
0.1 
0.1 
- 
33.2 
48.4 
5.5 
4.5 
2.7 
1.7 
1 
0.7 
0.2 
0.4 
0.3 
0.4 
0.2 
0.4 
0.5 
Trace 
Trace 
0.3 
26.7 
48.1 
9.1 
4.1 
4.2 
2.9 
0.8 
0.8 
0.2 
0.7 
0.3 
0.4 
0.3 
0.3 
0.5 
Trace 
Trace 
0.6 
26.1 
48.1 
9 
3.9 
4.5 
3.5 
0.8 
0.7 
0.1 
0.7 
0.3 
0.4 
0.2 
0.4 
0.6 
Trace 
Trace 
0.7 
*Adopted from Zhao et al.,2001 
 
Silks are produced in modified salivary glands for both the Lepidoptera and Diptera. 
Spiders, however, produce silks in multiple glands and typically use more than one type of silk to 
make their nests, traps and cocoons (Craig et al., 2002). A list of selected species (there are over 
34,000 species of spiders) and the corresponding gland that produces the silk is listed in Table 9.  
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Table 9: List of Lepidoptera, Diptera, and spider species and their silk producing gland 
Species Producing Gland 
Lepidoptera & Diptera  
Antheraea pernyi 
Antheraea yamamai 
Galleria mellonella 
Bombyx mori 
Bombyx mandarina 
Antheraea mylitta 
Chironomus tentans 
Salivary 
Salivary 
Salivary 
Salivary 
Salivary 
Salivary 
Salivary 
Spiders  
Nephila clavipes 
Nephila senegalensis 
Gasteracantha mammosa 
Argiope aurantia 
Araneus diadematus 
Latrodectus geometricus 
Araneus bicentenarius 
Tetragnatha versicolor 
Araneus ventricosus 
Nephila Clavipes 
Dolomedes tenebrosus 
Euagrus chisoseus 
Plectreurys tristis 
Argiope trifasciata 
Nephila madagascariensis 
Nephila clavipes 
Major ampullate  
Major ampullate 
Major ampullate 
Major ampullate  
Major ampullate 
Major ampullate 
Major ampullate 
Major ampullate 
Major ampullate 
Minor ampullate 
Ampullate  
Combined 
Larger ampule-shaped 
Flagelliform 
Flagelliform 
Flagelliform 
  * Adopted from Bini et al., 2004 
 
All of the organisms that produce silk synthesize task specific silk with divergent 
mechanical properties depending on its function (Scheibel, 2004). Adult spiders have seven 
different types of glands that yield four fibroin silks and three types of protein glue (Craig et al., 
2002). The type, function, and mechanical properties of spider silk and silkworm silk are shown 
in Table 10. For the purpose of the paper, only the glands that produce the fibroin silks are 
discussed.   
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Table 10: Comparison of extensibility, elastic modulus, and tensile strength of silks 
Silk Silk Gland Function Extension 
(%) 
Elastic 
modulus 
(GPa) 
Tensile 
strength 
(kpsi) 
References 
Dragline 
 
 
Minor 
 
 
Viscid 
 
 
Cocoon 
 
Major 
ampullate 
 
Minor 
ampullate 
 
Flagelliform 
 
 
Cylindrical 
(tubuliform) 
 
Salivary 
Orb web frame, 
radii, ampullate 
 
Orb web frame 
 
 
Prey capture, 
sticky spiral 
 
Reproduction 
 
35 
 
 
5 
 
 
200 
 
 
* 
10-50  
 
 
* 
 
 
* 
 
 
* 
400 
 
 
100 
 
 
100 
 
 
* 
Kaplan, 1997 
 
 
Kaplan, 1997 
 
 
Kaplan, 1997 
 
 
Kaplan, 1997 
Major and minor ampullate silk values are for N. clavipes. Similar values were found with silk 
from Areneus gemmoides. Flagelliform silk values are for Araneus diademadus. *Indicate that 
the values were not found. 
 
Most silks assume different secondary structures at different points during the in vivo 
processing. In general, there are two distinct structures categorized as Silk I and Silk II. Before 
spinning, the silk proteins are water-soluble with high molecular weights (Silk I). They are stored 
at high concentrations in their respective glands. This protein solution forms the silk dope which 
displays properties of a liquid crystal. In this state, the peptide motifs are thought to adopt an α-
helical conformation, β-turns, or random coil conformation. In spider dragline, the polyalanine 
motifs adopt an α-helical conformation, while the glycine-rich motifs form either β-turns or 
random coil conformation (Scheibel, 2004).  
The protein liquid crystal solution passes through the narrowing tubes of the spinning 
duct in both spider and silkworm glands. Here, water, sodium, and chloride are extracted from 
the solution. The pH is also lowered and initiates partial unfolding of the proteins. The silk 
proteins slightly extend, align, and pack much closer together (Scheibel, 2004). Partial 
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crystallization occurs parallel to the fibre axis. In spider dragline, as the hydrophobic polyalanine 
segments of the silk align, they are exposed to an increasingly hydrophobic environment, 
triggering their conversion from α-helical to β-pleated sheet structures (Scheibel, 2004). After 
spinning, it is then converted into water-insoluble fibers (Silk II) (Kaplan, 1997). 
Silk proteins exhibit impressive mechanical properties that have been shown to exceed 
that of high performance fibers such as Kevlar (Altman et al., 2002).  Table 11 shows the 
mechanical properties of B. mori silk and spider dragline silk from N. clavipes (which is 
regarded as nature’s high performance fiber) and compares them to other materials.. The stress-
strain curve for B. mori silk is shown in Figure 4. The highly organized structure of silk 
contributes to its mechanical properties 
Research has shown that the amphiphilic nature of the protein is responsible for the 
mechanical properties of silks having a unique combination of both strength and toughness 
(Altman et al., 2002).  The predominantly hydrophobic nature of the crystalline regions is 
essential to exclude water and in turn produce a high packing density of ß-sheet crystals that are 
believed responsible for the high strength and stiffness associated with the fiber, while the 
elasticity of the silk fibroin arises from the amorphous domain (Zhao et al., 2002).  This also 
explains why the silk is water insoluble, in which the water molecules are unable to penetrate the 
strongly bonded β-sheets. In addition, unlike globular proteins, silk fibers have extensive 
hydrogen bonding.  These properties provide silk fibers with superior environmental stability 
(Altman et al., 2002).  
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Table 11: Mechanical properties of silkworm and dragline silk compared to other materials 
Material UTS (MPa) Modulus (GPa) % Strain at 
break 
Authors 
B. mori silka (w/ 
sericin) 
500 5-12 19 Perez-Rigueiro et 
al. 
B. mori silkb (w/o 
sericin) 
610-690 15-17 4-16 Perez-Rigueiro et 
al. 
B. mori silkc 740 10 20 Cunniff et al. 
Spider silke 875-972 11-13 17-18 Cunniff et al. 
Collagenf 0.9-7.4 0.0018-0.046 24-68 Pins et al. 
Collagen X-linkedg 47-72 0.4-0.8 12-16 Pins et al 
PLA 28-50 1.2-3.0 2-6 Engelberg and 
Kohn 
Tendon 
(comprised mainly 
of collagen) 
150 1.5 12 Gosline et al. 
Kevlar (49 fiber) 3600 130 2.7 Gosline et al. 
Synthetic Rubber 50 0.001 850 Gosline et al. 
*Altman et al., 2003 
a
 Bombyx mori silkworm silk: determined from bave (multithread fibers naturally produced from 
silk worm coated in sericin). 
b
 Bombyx mori silkworm silk: determined from single brins (individual fibroin filaments 
following extraction of sericin). 
c
 Bombyx mori silkworm silk: average calculated from data in Cuniff, 1994. 
d
 Nephila clavipes silk produced naturally and through controlled silking. 
e
 Rat-tail collagen Type I extruded fibers tested after stretching from 0% to 50%. 
f
 Rat-tail collagen dehydrothermally cross-linked and tested after stretching from 0% to 50%. 
g
 Polylactic acid with molecular weights ranging from 50,000 to 300,000. 
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Figure 4: Stress-strain curves of (a) native B. mori silk fibroin fiber and (b)-(e) regenerated B. mori fibroin fibers 
after postspinning treatments.  The cross signs represent the experimental errors. *Adopted from Zhao et al., 2002 
 
 In the stress-strain curve, the silk material will not relax to its initial shape after the force 
is removed once it is past the elastic limit. Looking at only curve (a), the elastic limit is 
underneath the area before the line begins to curve. This is the point where the deformation 
(strain) of the material is irreversible (Zhao et al., 2002). This occurs in between the elastic and 
plastic regions of the stress-strain curve.  The silk material will actually break at the ultimate 
tensile strength (UTS) (located in the stress-strain curve Figure 4) (Zhao et al., 2002). 
B. mori silk has been used commercially as biomedical sutures for decades.  Although 
spider silks have also been well characterized, they have not been used for biomedical 
applications largely due to the predatory nature of spiders and the low level of production when 
compared to that of silkworm (Altman et al., 2003).  In addition, current research with precise 
silkworm silk fibers and films suggests that core silk fibroin fibers demonstrate analogous 
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biocompatibility in vitro and in vivo with other biomaterials such as collagen (Altman et al., 
2002).   
In silkworm silk derived from the cocoon of B. mori, the fibroin fibers are the core 
filaments and contain at least two major fibroin proteins. They are the heavy chain fibroin (325 
kDA) and a light chain fibroin (25 kDA). B. mori also produces a sericin coat that encases the 
core fibers. It is a glue-like protein that holds the two fibroin fibers together to form the 
composite fibers of the cocoon case.  The sequence of the core repeats in the fibroin heavy chain 
of the B. mori contains alanine-glycine repeats as well as serine or tyrosine (Altman et al., 2002).   
A study conducted by Wen et al. in 1990, indicated that there were some adverse effects 
including bioincompatibility and hypersensitivity to virgin silk (fibroin containing sericin gum).  
The adverse effects were attributed to sericin (Wen et al., 1990).  Recent studies demonstrate 
improved methods that completely extract sericin by boiling the cocoons, removing its antigenic 
effects. The resulting silk fibroin material produced immunological reactions similar to common 
biomedical materials such as polyesterene (Meinel, 2003 & Sofia, 2000). 
Silk is also an attractive material because of its slow degradation rate. This allows for a 
temporary scaffold that maintains mechanical integrity until host tissue regenerates. Studies have 
determined that silk is degradable over a long period of time because of proteolytic degradation 
often mediated by a foreign body response (Lam et al., 1995, Uff et al., 1995).  Most silk fibers 
lose the bulk of their strength within 1 year in vivo and are unrecognizable within 2 years 
(Altman et al., 2002).  Studies performed on silk in vitro have shown that proteases cleave the 
less-crystalline regions of the protein to peptides which are then able to be phagocytosed for 
additional metabolism by the cell (Asakura et al., 1997).  Studies have also demonstrated that 
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protease cocktails and chymotrypsin are able to enzymatically degrade silk (Asakura et al., 
1997).   
The highly organized structure of silk not only contributes to its mechanical properties 
but also affects its degradation.  Degradation rate can be altered by changing the content of the ß-
sheets.  A high content of ß-sheets causes the silk scaffold to degrade more slowly while a low 
content degrades fast. This is because more hydrogen bonding provides for closely packed sheets 
that make it more difficult for water molecules to penetrate and break the bonds. Therefore, by 
modifying the organizational structure of the ß-sheet the degradation rate can be more closely 
matched with bone tissue ingrowth at the implant site. 
Silk fibroin presents versatility in matrix scaffold design for an array of tissue 
engineering needs (Altman et al., 2002).  Scientists are able to process silk fibroin into foams, 
films, fibers and meshes (Minoura et al., 1995, Altman et al., 2002).  The change in morphology 
and architecture, such as pore size, porosity, and interconnectivity can be controlled based on the 
mode of preparation (Kim et al., 2004). This is critical to the in vivo mechanical behavior of the 
scaffold. To date, fabrication methods that have been utilized are solvent casting, particulate 
leaching, freeze-drying, gas foaming, melt molding, and phase separation (Nazarov et al., 2003) 
The diverse amino acid side chains allow for selective chemical couplings for tissue engineering. 
Also, it has been demonstrated that silk matrices promote cell attachment, proliferation, and 
differentiation. 
Studies conducted on silk scaffolds demonstrated the dependence of scaffold integrity on 
such properties as pore size and homogeneity.  It was reported that a more uniform pore 
distribution improved the mechanical properties of the scaffold (Kim, 2004).  Stress that is 
applied to the scaffold is concentrated at the pore interfaces, and if it is not uniform, quicker 
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deformation will occur as well as a decrease in compressive strength and modulus (Kim et al., 
2004). 
An example of silk’s matrix versatility is evident in research conducted by Dunn et al. in 
1992.  This study demonstrated that silk fibers are superior to collagen fibers and other enhanced 
scaffolds such as collagen fiber-PLA constructs (Dunn et al. 1992).  During the study, Dunn et 
al. analyzed the development of a collagenous anterior cruciate ligament (ACL) prosthesis.  The 
results showed inconsistent neoligament formation and considerable weakening of the collagen 
prosthesis in a rabbit model (Dunn et al. 1992).  They also utilized enhanced scaffolds such as a 
collagen fiber-PLA composite in order to maintain mechanical integrity to allow for neoligament 
tissue ingrowth (Dunn et al. 1992).  But in both studies, merely half of the structures stayed 
intact 4 weeks post-reconstruction.  This implied that the collagen and PLA composite was 
insufficient for the demanding in vivo environment of the ACL (Dunn et al. 1992).  However, 
silk fibroin fibers woven into a wire-rope geometry presented unique mechanical properties 
similar to that of the native ACL and supported host tissue ingrowth that surpassed that of 
collagen and the collagen/PLA construct (Altman et al. 2003).   
As discussed, an attractive characteristic of silk is its diverse amino acid side chains that 
can be modified.  Recent evidence suggests that a silk scaffold decorated with RGD, when 
compared with other integrin recognition sequences, increased osteoblast differentiation and 
mineralization in vitro (Sofia, 2000). 
 Other research demonstrates that the incorporation of a RGD peptide in a silk scaffold 
significantly increased the amount of calcium present after four weeks in culture compared to an 
undecorated silk scaffold (Meinel, 2004).The void area was completely filled with ECM which 
consisted of organized parallel collagen bundles and osteoblast-like cells, and few with 
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fibroblast-like morphology.  Both of the silk groups had more calcium deposition than the 
collagen scaffolds (Meinel, 2004). 
 This mechanical attachment of the intracellular cytoskeleton of cells to their extracellular 
matrix is important in modulating a number of cellular functions such as cell proliferation and 
migration. Integrins accomplish this by recognizing the arginine-glycine-aspartate (RGD) 
sequence motif located in proteins found in the ECM. RGD is a synthetic peptide that acts as 
active modulators of cell adhesion. This process is of interest to tissue engineers because it 
provides a means to control cellular function on a variety of matrices by covalently attaching 
RGD peptides to the surface of the material.  
Incorporating stem cells onto a scaffold has shown promise in generating engineered 
tissues and organs. Human MSCs have been researched in bone tissue engineering due to their 
capacity to differentiate into bone-making cells. The type of lineage adopted is dependent on the 
extrinsic signals from cytokines and other local signals.  Direct control of differentiation of 
hMSCs are currently represented by demonstration of osteoblastic differentiation in various 
biologically or synthetic derived matrices. These precursor cells are easily isolated and capable 
of in vitro proliferation and differentiation. They can then be cultured on a matrix in vitro prior to 
implantation to repair the defect or implanted immediately upon seeding (Pittenger et al., 1999).  
Human MSCs seeded on silk films and silk films covalently bound to the amino acid 
sequence (RGD) both in vitro and in vivo was studied by Meinel et al.  The in vitro analysis 
compared cells grown on tissue culture plastic (TCP; negative control), TCP coated with 
lipopolysaccaride (LPS; positive control) and collagen films.  The hMSCs formed monolayers on 
both of the silk films and clustered on the collagen film.  Cell proliferation was significantly 
higher on the silk films compared to the collagen or TCP.  These findings were substantiated by 
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in vivo studies in which the silk films, collagen film, and a PLA film were implanted 
intramuscularly into the quadriceps, triceps and rectus abdominus muscles (Meinel et al., 2004).  
Cell proliferation was advanced on the silk films, particularly on silk with RGD (Meinel et al., 
2004). 
  A study conducted by Meinel et al in 2004 substantiated the suitability to attach hMSCs 
to silk in order to promote bone formation.  Both silk and collagen scaffolds were studied with 
the same microstructure.  When cultured on the silk, stem cells expressed strong transcript levels 
of all three bone markers studied: bone sialoprotien (BSP), osteopontin and BMP-2.  They also 
accumulated bone-like matrix containing alkaline phosphatase and mineral. The bone formation 
resulted in interconnected trabeculae of bone-like tissue. Collagen scaffolds could not generate 
similar outcomes as a result of its rapid degradation.  
Research has also demonstrated that the osteogenic potential of a scaffold can be 
improved by incorporating certain bioactive molecules known to induce bone formation. 
Osteogenic molecules, particularly of the transforming growth factor (TGF)-ß superfamily, play 
a key role in bone formation and repair.  
Other osteoinductive bioactive molecules that are involved in new bone formation and 
remodeling include: 1) insulin-like growth factors (IGF); 2) skeletal growth factors (SGF); 3) 
transforming growth factors (TGF); 4) osteoblast derived growth factors (BDGFs); 5) epidermal 
growth factors; 6) vascular endothelial growth factors; 7) bone morphogenetic proteins (BMPs). 
Although BMP is one among a list of growth factors, it is the only one that is capable of 
transforming connective tissue cells into osteoprogenitor cells. 
BMPs induce undifferentiated mesenchymal cells to differentiate through the 
chondrogenetic or osteogenetic pathway. This can result in bone formation in non-osseous 
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environments. The BMPs accomplish this by forming a complex of two different types of 
serine/threonine kinase receptors: type I and type II. The receptors are induced at physiological 
and pathological ossification sites and are essential in the development of new bone. Once 
ligands bind to both the receptors, phosphorylation of type I occurs by type II. This 
phosphorylation results in an increase of specific molecules in the cell cytoplasm such as alkaline 
phosphatase and collagen synthesis. 
Bone morphogenetic proteins (BMP), including BMP-2-15, are members of the TGF-β 
superfamily and were initially identified as bioactive molecules in the demineralized bone 
matrix, discovered by Marshall Urist in 1965 (Sykaras et al., 2001). These can be further divided 
into three different subfamilies: BMP-2, BMP-3, and BMP-7. There have been over 15 BMPs 
cloned and expressed in humans and mice. The TGF-β superfamily is an assemblage of 
multifunctional cytokines which have vital roles in development and in the regulation of 
differentiation and proliferation of mesenchymal stem cells, including cartilage and bone 
formation (Scheufler et al., 1999). The cytokines act on mesenchymal cells in a concentration-
dependent manner, and are based on thresholds.  
The different isoforms of BMP have different roles in developmental processes during 
embryogenesis and during repair. For example, BMP 2-7 induce bone formation and 
differentiation. Bone morphogenetic protein-2 (BMP-2) is one of the key representatives of the 
collection of bone morphogenetic proteins (Scheufler et al., 1999). BMP-2 is synthesized as a 
453 amino acid proprotein which is glycosylated, proteolytically cleaved and dimerized to result 
in a mature homodimeric protein consisting of 114 C-terminal proprotein residues (Scheufler et 
al., 1999).  The dimensions of the dimer are 70 Å x 35 Å x 30 Å.   
 39 
Each monomer contains a cystine-knot that is assembled from six cystine residues, with three 
intrachain disulfide bridges.  Comparable cyseine-knots have been discovered in transforming 
growth factors, vascular endothelial growth factor, platelet derived growth factor, β nerve growth 
factor, brain-derived neurotrophic factor as well as gonadotropin (Scheufler et al., 1999).  
Because the proteins of this BMP family lack the familiar hydrophobic core that globular 
proteins contain, the cystine-knot scaffold is important in order to stabilize the structure.  BMP-2 
stabilizes itself additionally by dimerization, where a hydrophobic core is generated between the 
monomers (Scheufler et al., 1999).   
 Protein-based polymers, specifically silks, are logical choices for scaffolding for the 
formation of bone. It can be concluded from the literature that the reasons for the optimism are 
many-fold. Some of the reasons discussed included: 1) the natural role of the structural proteins 
of silks in tissue remodeling, including collagens in the ECM; 2) its biocompatibility (silks have 
been used as sutures) with potential resorbable properties; 3) the mechanical integrity (unique 
stress/strain/compression); 4) silks can be processed through varying techniques with the ability 
to control architecture; 5) suitable surface chemistry that can be decorated with a direct level of 
control (as shown through extensive research); 6) the ability to self-assemble. These important 
controls of polymer structure can potentially address the needs for bone tissue regeneration and 
provide an alternative, improved biomaterial for scaffolds. 
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III. Objectives 
 The objectives of this research are to characterize silk scaffolds in their ability to generate 
bone in critically sized femoral defects to be used in the treatment of bone disease and/or 
replacement.  The specific goals are: 
• To study silk as an alternative bone graft substitute to promote bone formation 
• To analyze the osseointegration of different silk +/-cytokines +/- cells combinations with BMP-
2 or RGD and hMSCs 
• To identify the most suitable combinations of scaffold and scaffold decorations to optimize 
bone formation 
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IV. Materials and Methods 
 
 The overall goals of the project were to determine if a silk fibroin is a suitable scaffold 
biomaterial for osseous treatments. The preparation and fabrication methods of the silk fibroin 
are discussed in the following section. The specifications of how osseointegration was measured 
are described in detail. 
 
7. Materials 
Fetal bovine serum (FBS), RPMI 1640 medium, Dulbecco’s Modified Eagle’s Medium 
(DMEM), transforming growth factor-ß3 (TGF-ß3) were from R&D System in Minneapolis, 
MN.  Basic fibroblast growth factor (BFGF) were from Life Technologies, Rockville, MD.  
Silkworm cocoons were supplied by M. Tsukada (Institute of Sericulture, Tsukuda, Japan) and 
Marion Goldsmith (University of Rhode Island, Cranston, RI). All other reagents were of 
analytical or pharmaceutical grade and obtained from Sigma (St. Lous, MO).  BMP-2 was a gift 
from Wyeth Pharmaceuticals, Andover, MA (Thomas Porter). Hexafluoro-2-propanol (HFIP) 
and methanol were purchased from Aldrich. 
 
8. Silk Preparation 
 
The processing of the silk was done at Tufts University at the Medford campus, MA. The 
basic principles of this process are shown in Figure 5 (Kaplan, 2000). After receiving the 
silkworm cocoons from Japan, the worm was extracted and 3 cocoons were cut into 8 parts.  The 
cocoons of B. mori silk were boiled for 1 hour in an aqueous solution of 0.02 Na2CO3 and 0.3% 
(w/v) Ivory soap solution.  The silk was completely submerged at all times.  Then the silk was 
rinsed with 1 L of hot unpurified tap water (UPW) and then 10 times with 1 L of cold UPW to 
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remove sericin proteins.  The silk was dried overnight in a fume hood and the dry weight was 
measured.   
The next day, the purified silk was dissolved in a 9 M LiBr solution at 55ºC for 5 hours to 
give a 10% (w/v) solution of dried silk.  The solution was filtered with a 5 µm syringe filter.  12 
mL of the filtered solution was then inserted into a Slide-a-Lyzer dialysis cassette and dialyzed 
against 1 L of UPW.  The UPW was changed after 1 hour, 3 hours, 6 hours, 9 hours and 12 
hours.  The dialyzed solution was pipetted into 25 ml aliquots in 50 ml Falcon tubes.  It was then 
lyophilized and dissolved in hexafluoro-2-propanol (HFIP) to give a 2-3% (w/v) solution, which 
was determined by weighing the remaining solid after drying.   
Films were formed by pipetting a volume of the solution onto the substrate (Falcon 
plates) to cover the surface area and then dried for 5 hours.  Disk-shaped scaffolds (5mm 
diameter by 3mm thick) were prepared from the parent scaffold by using a dermal punch and 
autoclaved.   
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Figure 5: Methodology for Silk Scaffold Preparation (Unpublished data, 2005) 
 
 
 
 
 
 
 
 
Boil and stir for 1 hour 
 
Rinse silk 
 
Dry overnight in fume hood 
Dissolve in 9 M LiBr solution at 55ºC for 5 hours 10% (w/v) solution of dried silk 
Filter solution with 5 µm syringe Insert 12 mL filtered solution into a Slide-a-Lyzer dialysis 
cassette 
Change UPW after 1 hour, 3 hours, 6 hours, 9 hours 
& 12 hours 
Pipet dialyzed solution into 25 mL 
aliquots in 50 mL Falcon tubes 
Lyophilize and dissolve in HFIP = 2-3% 
(w/v) solution 
Pipet solution onto Falcon plates and dry for 5 hours 
Disk shape scaffolds 5 mm x 2 mm by using a 
dermal punch 
B. mori silk cocoons + 1 L UPW + 0.02 M Na2CO3 + 0.3% (w/v) Ivory Soap 
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9. Silk Scaffold Fabrication 
 The fabrication technique utilized was salt leaching. A viscous solution was prepared by 
dissolving the silk in HFIP. Sodium particles acting as porogens were added to the plates and the 
silk/HFIP solution was then added (Unpublished data, 2005). In order to allow for homogenous 
distribution of the solution, the plates were covered to reduce evaporation rate. The solvent in the 
mixture of the silk/porogen composite was evaporated at room temperature. This composite was 
then immersed in methanol to induce β-sheet structure. The composites were then placed in 
water for 24 hours to ensure that all of the sodium particles had leached from the matrices. The 
fabrication process that follows the silk preparation is shown in Figure 6. 
 
 
Figure 6: Silk scaffold fabrication flowchart with HFIP-derived silk *Adopted from Nazarov et al. 
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10. Modification of Silk by Covalent Coupling of Peptides 
 
The silk films were modified, or decorated, with the following peptides: arginine-glycine-
aspartic acid (RGD) peptides or BMP-2 by covalently bonding the amines on the peptide with 
the silk fibroin.  The silk fibroin films that were cast after the addition of HFIP (as discussed 
above) were soaked in MES buffer (0.1 M MES, 0.5 M NaCl, pH 6) per dialysis cassette.  This 
was done to hydrate the films and change surface arrangement by exposing hydrophilic 
functional groups.  The MES buffer was changed the next morning.  The fabrication technique 
used to form porous three-dimensional matrices was salt leaching. 
The next evening the silk solution was carefully removed from the dialysis cassette and 
injected into a glass bottle with a syringe.  0.4 mg/mL of 1-ethyl-3-
(dimethylaminopropyl)carbodiimide hydrochloride (EDC) and 1.1 mg/mL N-
hydroxysuccinimide (NHS) were added to the solution and allowed them to react for 15 minutes 
at room temperature.  These reagents activate the γ carboxyl (COOH) groups from aspartic and 
glutamic acids, which represent 2-3% of amino acids based on the amino acid composition of 
silk fibroin.  The activated carboxyls are extremely reactive towards the primary amines on the 
peptides and form a stable covalent amide bond with the silk fibroin (Grabarek et al., 1990).   
Under a fume hood, 1.4 µl of 2-mercaptoethanol per ml solution were added in order to 
quench the EDC.  7.5 mg of RGD or BMP-2 was then added to the reaction mixture and allowed 
the proteins to react at room temperature for 2 hours.  The reaction was stopped by adding 10 
mM of hydroxylamine HCl.  This method hydrolyzes any unreacted NHS present on the silk’s 
surface and results in the regeneration of the original carboxyls.  Then 6-8 ml of the silk-RGD or 
silk-BMP-2 solution was inserted into a dialysis cassette and dialyzed against 1 L of UPW per 
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cassette.  The UPW was changed after 1 hour, 3 hours, 6 hours, 9 hours and 12 hours.  The 
dialyzed solution was pipetted into 25 ml aliquots in 50 ml Falcon tubes.  The solution was 
frozen for 2 hours at -75ºC.  It was then lyophilized until it was completely dried, leaving a 
porous matrix, taking approximately 3 days.  The silk films were subsequently treated with 90% 
methanol (v/v) to induce crystallization, induce a conformational change in silk to ß-sheets, and 
to prevent resolubilization in the cell culture media (Asakura et al., 1994).  The lyophilized silk 
solution was then stored at room temperature.  The basic methodology of this process is shown 
in Figure 7. This process starts off with the silk fibroin film that was cast after the addition of 
HFIP, as shown in Figure 5. 
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Figure 7: Process by which the silk was modified by covalent couplings of RGD peptides. Note: This process starts 
off with the silk fibroin film that was cast after the addition of HFIP, as shown in Figure 3. 
Hydrate silk fibroin film in MES buffer (0.1 MES, 0.5 M NaCl, pH 6/ dialysis cassette) 
Change MES buffer next morning  
Remove silk solution from cassette + 0.4 mg/mL of EDC + 1.1 mg/mL NHS   
Allow to react=15 minutes  
Under fume hood + 1.4 µl of 2-mercaptoethano/ml solution  
Mixture + 7.5 mg of peptide and allow to react for 2 hours  
Add 10 mM of HCL  
Insert 6-8 ml silk solution into dialysis cassette & dialyze against 1 L UPW/cassette 
Change UPW after 1 hour, 3 hours, 6 hours, 9 hours & 12 hours 
 
Pipette solution into 25 ml aliquots in 50 ml Falcon tubes 
Freeze solution for 2 hours at -75ºC  
Lyophilize silk solution for 3 days then add 90% methanol (v/v) 
Store silk solution at room temperature  
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11. Human Mesenchymal Stem Cell Isolation and Expansion  
The hMSCs were isolated and expanded according to previous methods discussed 
(Meinel et al., 2004). Whole human bone marrow (25 cm3 harvests) was obtained from Clonetics 
(Santa Rosa, CA) and was diluted in 100 mL of isolation medium (RPMI 1640 supplemented 
with 5% FBS).  The hMSCs were isolated by density gradient centrifugation.  The bone marrow 
suspension (20 mL aliquots) were overlaid on polysucrose (1.077g/mL, Histopaque, Sigma, St. 
Louis, MO) and centrifuged at 800 g for 30 minutes at room temperature.  The cell layer that 
formed was removed and washed in 10 ml isolation medium, pelleted and the contaminated red 
blood cells were lysed in 5 ml of Pure-Gene lysis solution. The cells were then pelleted and 
suspended in a medium of DMEM supplemented with 10% FBM and 1 ng/ml bFGF and seeded 
in T75 flasks at a density of 5 x 103 cells/cm2. 80% confluence was reached after 12-17 days for 
the first passage (P1). The cells were trypsinized, replated, and passaged for a second time (P2) 
reaching 80% confluence after 7 days. The P2 cells were used for the experiments (Meinel et al., 
2004). 
 
12. Operative Procedure 
 Surgery was performed on one hind limb and the full length of the femur was exposed. A 
5 mm critically sized defect was created in the rodents’ femur. Silk implants were then placed 
into the defect. The specimens were administered the appropriate medication and observed on a 
daily basis over an eight week period. 
 12.1 Femoral Segmental Defect 
Prior to the surgery, 8 male nude rats weighing 325-375 g were administered 
buprenorphine subcutaneously (0.05mg/kg) and procaine penicillin intramuscularly 
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(200,000IU/kg).  They were labeled #69-76 and weighed before undergoing surgery.  They were 
anesthetized with isoflurane (4-5%) and 1000 mL/min of O2 and then transferred to the surgical 
table where anesthesia at 0.5-2% isoflurane and 600 mL/min of oxygen were administered 
through a nose cone face mask. Once the anesthesia was administered, the rat’s respiratory rate 
and pattern were monitored every 5 -10 minutes throughout the surgery.   
The anesthetized rat was positioned in left lateral recumbancy and one hind limb was 
prepared and draped in a sterile fashion.  An approximately 25 mm long skin incision was made 
cranial to the femur and continued distally to the level of the lateral femoral condyle (Figure 8A).  
The subcutaneous tissue, facia lata, and lateral facia of the vastus muscle were carefully incised 
and separated.  Retraction tools were used to pull the biceps femoris muscle posteriorly and the 
vastus muscle was retracted anteriorly.  This exposed the full length of the femur (Figure 8B).  
An aluminum external fixation plate (15x4x4 mm) was placed over the lateral aspect of the 
femur and positioned appropriately in order to drill 4 holes in the bone, 2 in the proximal 
metaphysis and 2 in the distal metaphysis (Figure 8B).  Once the drilling was complete, four 0.99 
mm transverse-threaded Kirschner wires were extended 0.5 mm beyond the transcortex which 
was marked by a black line on the screws (Figure 8C, D, and E).  Small incisions were made to 
the skin caudal to the 25 mm incision allowing it to be pulled over the Kirschner pins.  The 
external fixator was then secured to the pins (Figure 8F).  A 5 mm critical-sized full-thickness 
defect was created in the diaphysis with a 5 mm cutting burr while the area was irrigated with 
saline solution to remove bone debris as necessary (Figure 8F). The implants were then inserted 
into the defect (Figure 8G, H).  Upon insertion, the muscle and subcutaneous tissues were 
sutured with a 4-0 Maxon suture.  The skin was then closed separately with at 4-0 PDS II suture.   
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Figure 8: Surgical procedure for placing silk scaffolds in critical size femoral defects. A) skin incision, B) using 
fixator plate as a template for drilling, C) drilling pin hole, D) placing fixator pins, E) cutting pins, F) empty defect 
with fixator plate, G) placing implants into defect, H) defect with implants 
 
Implanted in each femoral defect were two silk scaffolds placed longitudinally along the 
defect.  A diagram of the external fixator and placement of the scaffolds are shown in Figure 9. 
The defects were filled with one of a series of different silk +/- cell +/- cytokine implant 
combinations that was based on the results of the heterotopic implantations (Table 12). 
A 
C 
E 
G
B
D 
F 
H 
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Figure 9: Critical size femoral defect fixed externally with a plate 
 
 
Table 12: Scaffold Groups 
Rat # Treatment Group# 
69 Defects with tissue-engineered scaffolds 
covalently bound to RGD 
3 
70 Scaffolds with covalently bound RGD and 
undifferentiated hMSCs 
4 
71 Scaffolds with covalently bound RGD and 
undifferentiated hMSCs 
4 
72 Scaffolds with covalently bound RGD and 
undifferentiated hMSCs 
4 
73 BMP-2 loaded scaffold and undifferentiated hMSCs (seeded the day before the surgery) 
7 
74 Empty defect 1 
75 Scaffolds with covalently bound RGD only 2 
76 Scaffolds with covalently bound RGD only 2 
 
12.2 Post-Operative Procedure 
Immediately following surgery, the rats were administered 5 mg/kg of Carprofen 
subcutaneously.  Each rat was wrapped in a paper towel and placed in a clean cage with heat 
provided by a heat lamp and monitored for cognizance every 15 minutes for 1 hour until the rat 
was ambulatory and cognizant of its environment.  The rat was then administered 0.025 mg/kg 
 52 
Burenorphine subcutaneously 8 hours and 16 hours post-op.  At 24 hours post-op, they were 
given 5 mg/kg of Carprofen and 0.025 mg/kg Buprenorphine subcutaneously and 200,000 IU/kg 
Procaine Penicillin intramuscularly.  The weights of each animal were recorded.  At 32 hours 
post-op, another 0.025 mg/kg of Buprenorphine was administered subcutaneously if the animal 
appeared to need it.  At 48 hours post-op, the rats were given 5 mg/kg Carprofen subcutaneously 
and 200,000 IU/kg procaine penicillin intramuscularly.  Each rat was then weighed again.  
Depending on the condition of each rat, additional doses of Carprofen were administered once 
every 24 hours and doses of Buprenorphine were administered every 12 hours if needed.  If the 
rats need any additional doses of procaine penicillin, it was administered, but not more than a 
total of 4 doses.  
Each rat was weighed twice a week until the study was complete.  They were weighed more 
often if excessive weight loss was observed.  As needed, the surgical wound was cleaned with 
chlorhexiderm and alcohol.  Each rat was checked twice per day noting the following:  
• Attitude and response to contact 
• Changes in behavior, activity or posture,  
• Pain or discomfort evidenced by twitching, falling over, back arching or lameness 
• Observing the procedure area for redness, swelling, discharge or dehiscence 
• Ensuring adequate daily food and/or water consumption 
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13. Scanning Electron Microscopy (SEM) 
 The segments of the silk scaffolds were fractured in liquid nitrogen (Kim et al., 2004).  
The specimens were sputter coated with gold.  The scaffold’s morphologies and poor 
distributions, sizes and interconnectivity were observed with a LEO Gemini 982 Field Emission 
Gun SEM (Kim et al., 2004).  The pore sizes were determined by measuring random samples of 
100 pores from the SEM images using ImageJ software developed at the US National Institutes 
of Health (Kim et al., 2004).   
 
14. Radiographs 
Radiographs of the femoral defect were taken every two weeks to observe the progress of 
bone formation.  The animals were sacrificed 8 weeks post-operation via carbon dioxide 
suffocation.  The external fixator and implant remained in place following sacrifice.  A 
qualitative evaluation from the X-rays was performed based on the bridging of the defect and the 
percentage of bone ingrowth following the qualitative measurements defined in Table 13.  The 
evaluation from the X-rays was performed by 2 independent observers.  
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Table 13: Qualitative X-ray Measurements 
Bridging of Defect Parameters Percentage of Bone Ingrowth Parameters 
Grade 1: trace radiodense material in the 
defect 
Grade 1: minimal new bone composed of 
noncontiguous areas of minimal density 
Grade 2: flocculent radiodensity with flecks 
of calcification and incomplete bridging of 
the defect 
Grade 2: new bone present as mostly 
contiguous areas of normal density and 
filling<50% of defect 
Grade 3: bridging of the defect in at least one 
location with material of non-uniform 
radiodensity 
Grade 3: new bone present as mostly 
contiguous areas of normal density and fills 
51-95%  of the defect 
Grade 4: bridging of the defect at both the cis 
and trans cortex with material uniform 
radiodensity, cut ends of cortex remain 
visible 
Grade 4: new bone a solid contiguous mass 
that fills>95% of the defect 
Grade 5: obscuring of at least one of the two  
cortices by new bone 
 
Grade 6: bridging of the defect by uniform 
new bone, cut ends of cortex not seen 
 
 
15. Dual Energy X-ray Absorptiometry (DEXA) Scanning 
 Following euthanasia after eight weeks post-operative, the femurs were scanned using a 
Hologic QDR 1000W with the regional high resolution scan mode. The external fixators and k-
wires remained in the femur. A general, or global, region of interest was selected to include the 
area of the defect in addition to the proximal and distal portions of the femur. The k-wires were 
not included in the selected area. There were three subregions selected to only include the defect 
area. Region 1 was a small area the same size as the defect. Region 2 was approximately 5 mm 
in height with a length three times the width of the defect. This would provide a means to include 
any bone or callous formation that occurred beyond the defect region. Region 3 was the same 
length as region 2, however it was half of the height. This placed it directly in the center of the 
defect. 
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 Each specimen was scanned twice with a third scan taken if the scans varied more than 
5%. In this case, the two closest were averaged to obtain the values. The values determined from 
the DEXA scans were bone area (cm2), bone content (g), and bone mineral density (g/cm2). The 
obtained values for regions 1-3 and the global values can be found in Appendix C. 
 In order to have control values to compare the defect data with, scans were taken of the 
healthy femur on the opposite leg. This was done in the same manner as described above. A 
global region and regions 1-3 were acquired and these values can be found in Appendix D. 
Similarly, the values that were obtained were bone area (cm2), bone content (g), and bone 
mineral density (g/cm2). 
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V. Experimental Design  
 This section explains the rationale behind the processes that led up to a final silk matrix. 
These include matrix fabrication, control of the architecture, and decoration. Such controls were 
analyzed using SEM, DEXA, and radiographs. 
16. Matrix Preparation 
  
 Based on data gathered in a previous study conducted at Tufts University, a salt leaching 
method was adopted in the experiment. The research analyzed three methods of scaffold 
preparation for silk based on their prior use in processing of other types of polymers (Nazarov, 
2003). These included freeze-drying, salt leaching, and gas foaming. The most promising 
methods were determined by comparing the mechanical properties (compressive resistance) and 
porosities. 
 For the freeze-drying method, the scaffolds that formed were highly interconnected and 
porous however the pore sizes were very small (Nazarov, 2003). The porosities were 99% 
regardless of the variables studied (Table 14). The pores were larger with the salt leaching 
method (202) in comparison to the freeze-drying method. The pore structure, however, was not 
as highly interconnected. NaCl was used as a porogen in this method and was leached out in 
water to form the porous matrix (Nazarov, 2003). Scanning Electron Microscopy (SEM) images 
showed that the gas foaming method also had a highly interconnected pore structures compared 
to salt leaching (Figure 10) with pore sizes around 155 (Nazarov, 2003).  However, as the 
porosity increased the scaffolds were not as strong and flaked apart. The salt leaching and the gas 
foaming methods had varying porosities as the porogen-to-silk ration was varied (Table 14) 
(Nazarov, 2003). The complete data are shown in Table 14. The mechanical data that was 
collected can be found in Table 15. 
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Table 14: Porosity and Density of the Scaffolds (Average ± S.D., N=3) for Porosity and Density 
Measures (for Pore Sizes, N= 200) 
Methods Sample Ε (%)a 
 
Density 
(mg/mL) 
Pore Size 
Gas foaming 
 
 
Salt leaching 
 
 
Freeze-drying 
(frozen at -20ºC) 
 
 
 
(frozen at -80ºC) 
 
 
 
NH4HCO3/silk (wt %) 
10:1 
20:1 
NaCl/silk (wt %) 
10:1 
20:1 
alcohol treatmentb 
15% methanol 
25% methanol 
15% propanol 
25% propanol 
15% methanol 
25% methanol 
15% propanol 
25% propanol 
 
87.0 ± 2.0 
97.0 ± 1.0 
 
84.0 ± 2.0 
98.0 ± 1.0 
 
98.0 ± 0.10 
99.0 ± 0.01 
98.0 ± 0.01 
99.0 ± 0.20 
99.0 ± 0.30 
99.0 ± 0.03 
97.0 ± 0.20 
99.0 ± 0.02 
 
100 ± 10 
40 ± 5 
 
120 ± 2 
40 ± 13 
 
20 ± 2 
30 ± 1 
30 ± 3 
30 ± 3 
50 ± 3 
40 ± 1 
30 ± 3 
30 ± 5 
 
155 ± 114 
 
 
202 ± 112 
 
 
 
50 ± 20 
 
 
 
15 ± 7 
 
a
 Porosity. b Weight ratio of water in alcohol. *Adopted from Nazarov et al. 
 
 
 
Figure 10: SEM images of the inner and outer structure of the silk scaffold by salt leaching and gas foaming after 
methanol treatment (scale bar: 200 µm) a.) NaCl:silk (10:1 wt%) (inner) b.) NaCl:silk (10:1 wt%) (outer) c.) 
NH4HCO3:silk (10:1 wt%) (inner) d.) NH4HCO3:silk (10:1 wt%) (outer) *Adopted from Nazarov et al. 
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Table 15: Compressive Stress and Modulus of the Silk Scaffolds  
Method Sample Alcohol 
Treatmenta 
Compressive 
Stress (kPa) 
Compressive 
Modulus (kPa) 
gas foaming 
 
 
 
 
 
salt leaching 
 
 
 
 
 
 
freeze-drying 
NH4HCO3/silk (wt %) 
10:1 
 
20:1 
 
 
NaCl/silk (wt %) 
10:1 
 
 
20:1 
 
 
freeze temperature 
 
 
-20 ºC 
 
 
 
 
-80 ºC 
methanol 
1-butanol 
2-propanaol 
methanol 
1-butanol 
2-propanol 
 
methanol 
1-butanol 
2-propanol 
methanol 
1-butanol 
2-propanol 
 
none 
15% methanol 
25% methanol 
15% 2-propanol 
25% 2-propanol 
none 
15% methanol 
25% 2-propanol 
15% methanol 
25% 2-propanol 
280 ± 4 
230 ± 9 
250 ± 28 
250 ± 21 
150 ± 8 
100 ± 11 
 
30 ± 10 
150 ± 14 
100 ± 20 
175 ± 3 
250 ± 4 
200 ± 3 
 
80 ± 1 
10 ± 2 
10 ± 3 
10 ± 2 
10 ± 3 
20 ± 2 
20 ± 3 
5 ± 4 
30 ± 2 
20 ± 1 
900 ± 94 
500 ± 37 
800 ± 44 
1000 ± 75 
300 ± 40 
200 ± 30 
 
100 ± 2 
400 ± 50 
400 ± 58 
450 ± 94 
490 ± 94 
790 ± 3 
 
170 ± 7 
20 ± 1 
10 ± 3 
40 ± 4 
50 ± 8 
220 ± 7 
90 ± 21 
90 ± 40 
100 ± 1 
130 ± 1 
a
 100% unless otherwise indicated, weight percent of the alcohol in water. *Adopted from 
Nazarov, et al. 
 
Table 16: Average Compressive Strength and Average Compressive Modulus of Gas Foamed 
and Salt Leached Scaffold at 1% and 2% Strain under Compressive Load (N=2) 
Scaffold Porogen 
Ratio 
Average 
Compressive 
Modulus (KPa) at 
1% strain 
Average 
Compressive 
Strength (KPa) at 
1% strain 
Average 
Compressive 
Modulus (KPa) 
at 2% Strain 
Average 
Compressive 
Modulus (KPa) 
at 2% Strain 
Salt leached 
 
 
Gas formed 
 
10:1 
20:1 
 
10:1 
20:1 
 
40 
1600 
 
500 
5000 
 
0.40 
16 
 
5 
50 
 
400 
1200 
 
200 
3000 
 
8 
24 
 
16 
60 
*Adopted from Nazarov, et al. 
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 The gas foamed scaffolds reached a definitive compressive yield point where the scaffold 
was permanently deformed. However, the salt leached scaffolds demonstrated characteristics that 
were more ductile and sponge-like in behavior (Nazarov et al., 2003). Table 15 shows that the 
gas foamed scaffolds had a higher compressive strength and compressive modulus than the salt 
leached scaffolds. However, both of the methods were comparable in terms of mechanical 
properties with other polymeric biomaterial scaffolds used in bone tissue engineering (Nazarov 
et al., 2003). In bone related engineering applications, matrices are designed to hold a load 
allowing for 1-2% strain. The gas foamed and salt leached scaffolds prepared with methanol 
were analyzed as a load is applied (Table 16). Of the scaffolds prepared, these groups were 
determined to be the most likely used in bone engineering applications (Nazarov et al., 2003).  
 Although the scaffolds formed by gas foaming had higher compressive properties and 
porosity based on the above study, the salt leaching method was adopted in the present 
experiment. The characteristics shown from the salt leaching method meet the requirements 
related to bone tissue engineering. Additionally, after speaking with Dr. Kaplan and Dr. Kirker-
Head of Tufts University, it was established that the salt leaching method would suffice for the 
experiment. 
 Methanol is used in order to induce a conformational change in the silk (silk I) to the 
crystalline ß-sheet structure (Nazarov et al., 2003). When methanol is immersed in the silk 
solutions, water is removed from the hydrated hydrophobic domains and increases chain-chain 
contact and formation of ß-sheet structures. Other alcohols, such as 2-propanol, are less 
hydrophilic and therefore are less miscible with water (Nazarov et al., 2003). When immersed in 
the silk solution, less dehydration occurs and fewer ß-sheet structures are induced when 
compared to methanol treated scaffolds. In the present experiment 90% methanol is used to 
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induce transformation (Nazarov et al., 2003). Studies have shown that with an increase in the 
concentration of methanol, the compressive modulus is also increased. This is due to the increase 
in crystallinity of the silk after introducing the methanol. Additionally, at a higher concentration, 
the chain rearrangements are more rapid and extensive and lead to an increase in ß-sheet content 
(Nazarov et al., 2003). 
 The pore size and the porosity of the scaffolds were regulated by the addition of granular 
NaCl with particle sizes ranging from 100-1000 µm in diameter. In this process, most of the salt 
particles were retained in the scaffold while the surface of the salt dissolved in the fibroin 
solution. Previous studies observed that the solubility of the silk protein decreased when NaCl 
concentration was increased (Kim et al., 2004). With a higher salt concentration, more water 
molecules are needed to hydrate the ions. As a result, the water molecules are easily removed 
from the fibrous proteins and interactions among the proteins becomes favored. This provides for 
a more stable structure and the induced chain-chain interactions result in ß-sheet formation (Kim 
et al., 2004). 
 
17. Characterization of Matrix 
 The silk scaffolds were characterized by Scanning Electron Microscopy (SEM) to 
determine the porosities and homogeneity in structure (Unpublished data, 2005). The pore size 
was calculated from means with at least 100 pores determined by image analysis and the values 
were reported as a means ± standard deviation (Unpublished data, 2005). This analysis was 
conducted before any peptides or cells were incorporated into the scaffold. Similar analyses were 
also conducted after cell and bone growth to determine any changes in the structure and the 
distribution of the changes (Unpublished data, 2005). This technique is routine in the labs at 
Tufts University. 
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18. Peptide Coupling 
 
 Another objective in designing the experiment was to assess the role of cell signaling 
factors immobilized on silk as a biomaterial template.  Preliminary tests were conducted with 
different combinations and concentrations of different signaling factors (Unpublished data, 
2005).  These included GRGDS containing the adhesion ligand RGD, GRYDS (control), the first 
34 amino acids of parathyroid hormone (PTH1-34) and a modified version of PTH1-34.  Each of 
the following signaling factors is related to the induction of bone formation.  The GRGDS 
peptide was selected on the basis of being well-documented and the interaction between the 
GRGDS sequence found in fibronectin and integrins (Unpublished data, 2005).  GRYDS is used 
as a control sequence in order to compare to RGD. Preliminary studies were conducted to clarify 
the role of the control RYD versus RGD and PTH 1-34 versus the modified PTH 1-34 and also 
to use the information found in the next phase of the study (Unpublished data, 2005).  
 In preliminary studies, the adhesion of human osteoblast like cells were analyzed after 4 
hours of attachment to the substrates in the presence of 1% and 10% serum or no serum 
(Unpublished data, 2005).  In serum free cultures, significantly more cells adhered to the 
RGD/silk, PTH/silk substrates than to silk alone.  The adhesion of the cells to the control 
substrates was comparable to that of silk (Unpublished data, 2005).  Similar results were found 
when bovine mesenchymal stromal cells were incorporated into the scaffolds (Figure 11).   
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Figure 11: Adhesion of bovine mesenchymal stem cell fibroblasts to silk substrates in the presence or absence of 
serum *Adopted from Sofia et al., 2000 
 
The number and size of the nodules found in the culture were also determined 
(Unpublished data, 2005).  According to the work of Bellows et al., if numerous nodules are 
found in the culture, it provides a rough estimate of the osteoprogenitor cells present that are 
capable of proliferating and differentiating (Bellows et al., 1989).  If there are few large nodules 
present, it can be presumed that there are fewer osteoprogenitor cells, but the osteoblasts present 
in the nodule are rapidly differentiating and increasing mineralization of the matrix (Bellows et 
al., 1989).   
The number of nodules determined on each substrate is found in Figure 12A (Sofia et al., 
2000).  By 4 weeks of culture, there were no significant changes observed except with RGD/silk 
substrate with a 25% increase in the number of nodules.  This suggests that the number of 
osteoprogenitors is rapidly increasing on this substrate (Sofia et al., 2000).  It was also found that 
nodule area increased on the RGD substrate, insinuating increased osteoblast differentiation 
(Figure 12B) (Sofia et al., 2000).  The response of the osteoblasts to the decorated silk supports 
silk as a suitable bone-inducing matrix.  The results confirm that this is particularly true for the 
RGD/silk substrates, but not for either PTH substrate (Sofia et al., 2000).  This provided a means 
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to narrow the choices for the type of surface modification used. The next phase focused only on 
the peptide RGD and the growth factor BMP-2 (Sofia et al., 2000).  Because the PTH substrates 
did not prove to serve as suitable matrices, another peptide related to bone formation was studied 
(BMP-2). BMP2-7 plays an active role in bone development and growth where BMP-2 was used 
in the following experiments because it was graciously donated by Wyeth Pharmaceuticals. 
 
Figure 12: (A) Nodule numbers and (B) areas formed by the Saos-2 osteoblast-like, human osteoblasts grown on 
the various silk films at 2 and 4 weeks. *= p < 0.05 compared to control (silk). **Adopted from Sofia et al., 2000 
 
 
19. Model System 
Living animals are required for this study due to the complexity of the processes being 
evaluated and therefore were unable to be duplicated or modeled in simpler systems 
(Unpublished data, 2005). Additionally, there is little known about bone morphogenesis and 
repair processes that would allow an appropriate nonliving model. In addition, preclinical studies 
in living animals are necessary prior to human testing (Unpublished data, 2005). 
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Since these investigations are evaluating a novel material and there has not been 
extensive research before this point, a rodent model is typical. Once it is demonstrated that silk is 
a promising material for orthopedic applications, the animal model system can progress to larger 
animals with a similar bone physiology to humans (Unpublished data, 2005).  
Rats are a well established model for testing osteoinductive materials when combined 
with carrier substrates (Unpublished data, 2005). Therefore, the animal model system of choice 
was the nude rat. Rats are financially feasible in comparison to larger animals.  The use of nude 
rats also allows the use of non-rodent cell types because they lack an immune response and 
therefore will not reject human mesenchymal stem cells upon implantation (Unpublished data, 
2005). This species has been selected because a large database exists which would allow 
comparisons with previous data. Nude rats are also the phylogentically lowest species that 
provides adequate size, tissue, and anatomy for the proposed study (Unpublished data, 2005). 
Additionally, the background of this project was established in previous studies at Tufts using 
the nude rat species.   
 The number of rats required for the study of silk as a scaffold for bone tissue regeneration 
is 328 over a period of three years.  During this time, it is intended to complete 66 heterotopic 
implantations.  To date, Tufts has used 35 rats for this study.  This total will provide 
approximately 100 combinations of silk +/- cytokine +/- cells.  Additionally, there have been 37 
out of 200 rats approved for this phase of the study, which is assessing orthotopic bone formation 
in vivo in critically-sized femoral defects. This enables up to 40 combinations of silk +/- cytokine 
+/- cells in these defects to be tested. 
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20. Assessment of in vivo Bone Formation 
 In order to determine the osteogenic potential of the silk scaffolds post-implantation, 
plain radiographs were taken at 0, 2, 4, 6, and 8 week intervals. This method provides a means to 
qualitatively determine whether or not bone formation has occurred. It provides a means to 
visually account for density changes. In order to obtain quantitative data to better understand 
how the scaffold combinations affected bone ingrowth, DEXA analyses were performed post 
mortem. These forms of analyses were suggested by Dr. Kaplan and Dr. Kirker-Head from Tufts 
University. They were also performed in the preliminary studies and therefore to maintain 
consistency in evaluating results, the preceding methods were adopted in this phase of the 
experiment. 
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VI. Results 
 
21. X-ray Evaluation 
 
 The defects with the RGD covalently bound to scaffolds with TE hMSCs (Rat 69) and 
one rat in the RGD and undifferentiated hMSCs (rat 72) showed trace radiodense material 
(Figure 13A) and minimal new bone (Figure 13B) for all time points. There was minimal bone 
ingrowth for Rat 71 (RGD and scaffold with undifferentiated hMSCs), and Rat 75 and 76 (RGD 
scaffold only) for all time points. The addition of hMSCs (both undifferentiated and TE) to the 
scaffolds with covalently bound RGD did not induce bridging of the defect or percentage of bone 
ingrowth. The results were comparable to that of the RGD covalently bound to scaffolds only.  
 Healing was evident in the X-rays for Rat 73. The scaffolds loaded with BMP-2 showed 
bridging of the defect in at least one location with material of non-uniform radiodensity. Bone 
ingrowth of normal density and filling was present in less than 50% of the defect (Figure 13B). 
Both occurred in the sixth week post-operative. Results comparing the addition of 
undifferentiated verse tissue engineered hMSCs could not be made since only BMP-2 loaded 
scaffolds with undifferentiated hMSCs were used in this experiment.  
 These results show that the BMP-2 loaded scaffolds with undifferentiated hMSCs and the 
empty defect induced bridging of the defect and bone ingrowth. Although the latter obscured the 
most of the two cut cortices and formed new bone in more than 50% of the defect, the results 
were unexpected.  
 It should be noted that results are not available for rat #70. It was a member of the 
treatment group with RGD covalently bound to the scaffolds with undifferentiated hMSCs. The 
death occurred two days post-surgery and was possibly the result of a reaction to the injections. 
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The death of the rat does not have an impact on the results obtained since there were still two 
other rats in the same treatment group in this phase of the experiment. 
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Figure 13: Qualitative analyses for bridging of the defect and percentage of bone ingrowth are shown in graphs A 
and B respectively. This scoring was done for defects with RGD covalently bound to scaffolds with tissue-
engineered hMSCs (Rat 69), defects with RGD covalently bound to scaffolds with undifferentiated hMSCs (Rat 71 
and Rat 72), defects with BMP-2 loaded scaffolds with undifferentiated hMSCs (Rat 73), empty defects (Rat 74), 
and defects with RGD covalently bound to scaffolds only (Rat 75 and Rat 76). 
 
 The final X-rays from the different rats are presented in Figure 14. All of the radiographs 
taken at each time period can be found in Appendix B. There is minimal healing in A, B, C, F, 
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and G. It should be noted that the below X-rays demonstrate that the most activity is occurring in 
E which is counterintuitive considering that it is the empty defect.  
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Figure 14: X-rays that were taken of the femoral defect of Rat 69 (A), Rat 71 (B), Rat 72 (C), Rat 73 (D), Rat 74 
(E), Rat 75 (F), and Rat 76 (G). 
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22. DEXA scanning 
 The results obtained from qualitative scoring of the X-rays were compared with DEXA 
scanning after the rats were euthanized (Figure 15). The values that were obtained for bone area, 
content, and mineral density for the defected area can be found in Appendix C. In general, rats 
69, 71, and 72, which had the scaffolds with covalently bound RGD with hMSCs, showed the 
least bone ingrowth (Figure 15). However, the density for Rat 72 was higher than for Rat 71 
even though they are both in the same group (RGD and undifferentiated hMSCs). 
 The density of the new bone was highest for rat #75 (0.2121 g/cm2) with the RGD 
scaffold implanted in the defect. However, Rats 73, 74, &75 did not show a significant 
difference in the area, mineral content, and mineral density of the newly formed bone. Rat 76 
had similar mineral density, area and content values to Rat 72 and 69 (Figure 15).  
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Figure 15: DEXA scanning of femoral defect with implants for mineral density (g/cm2), area (cm2), and bone 
content (g). The data is from each rat: RGD covalently bound to scaffolds with tissue-engineered hMSCs (Rat 69), 
RGD covalently bound to scaffolds with undifferentiated hMSCs (Rat 71 and Rat 72), BMP-2 loaded scaffolds with 
undifferentiated hMSCs (Rat 73), empty defects (Rat 74), and RGD covalently bound to scaffolds only (Rat 75 and 
Rat 76). 
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 The average values for Regions 1-3 were also compared to control values for bone 
mineral content, area, and density that were obtained from analysis of the healthy, unaffected 
femur (Figure 16A-C). The bone content and area values remained extremely small (if not zero) 
compared to the control values for rats 69, 71, and 72 (of which, 71 and 72 are in the same 
group), the bone density was closer to the control for rat #72. The control bone density value was 
58% higher than the recorded DEXA value. Rat #72 also had slightly increased values for 
bridging of the defect scoring compared to rat #71 (Figure 13A). The radiographs also 
corroborate the DEXA in regards to Rat 69. The X-rays showed trace radiodense material and 
minimal bone ingrowth and according to Figure 15, Rat 69 has the smallest bone density value 
compared to the other specimens. 
 The bone mineral density values for Rats 73, 74, and 75 are closest to their corresponding 
control density values. The control bone density values were 25%, 18%, and 14% higher than the 
recorded values for Rats 73, 74, and 75 respectively (Figure 16A). The qualitative analysis 
confirms this for Rats 73 and 74. However, there is little bone growth activity occurring in the 
defected area of Rat 75 according to Figure 13. In the X-ray evaluation, rats 75 and 76 showed 
new bone area and content comparable to rats 71 and 72. Both of the groups (rats 75 &76 
members of group 2 and rats 71 &72 members of group 4) displayed minimal new bone and 
bridging in the X-rays (Figure 14B, C, F, and G). Therefore, the qualitative analysis for Rat 75 is 
not corroborated by the DEXA analysis.  
 Rats 73, 74, and 75 also shows high bone mineral content and area within a decent range 
to the control values in comparison to the other rodents. For rat 73, the control values were 33% 
higher compared to the defected bone area value, and 48% higher compared to content. 
Similarly, for rat 74, the control values were 51% and 41% higher than the values recorded 
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within the defect for bone content and area respectively (Figure 16A, B). This, however, is 
corroborated by the qualitative evaluation (Figure 13A & B). The control values were 59% and 
55% higher than the defected values for content and area respectively for rat 75.  
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Figure 16: The average DEXA values (Regions 1-3) were compared to control values of the healthy, opposite hind 
limb of the rodents (A) Bone mineral density values were compared to control density values (B) Bone area values 
were compared to control area values (C) Bone mineral content values were compared to control content values22 
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22. Morphology 
 The HFIP-derived scaffolds are characterized by a highly interconnected network of 
pores and smooth surfaces (Figure 17). The pore sizes had an average diameter of 890±50 µm. In 
preliminary studies with HFIP silk scaffolds, the pore sizes followed a Gaussian distribution due 
to the NaCl porogens not being sieved. Passage 2 hMSCs were seeded onto the HFIP-derived 
silk and were analyzed after 1, 14, and 28 days. SEM analysis demonstrated that the distribution 
of the hMSCs was non-uniform (Figure 17). 
 
 
 
Figure 17: SEM of hMSCs in HFIP silk scaffolds. The images in the right column are magnified images of the 
boxed areas in the left column. 
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VII. Discussion 
 
 This study reports tissue-engineering of bone-like structures, investigating hMSCs 
(isolated from bone marrow), BMP-2 delivery, and silk fibroin scaffolds (in some cases 
decorated with RGD sequences). The in vivo DEXA results demonstrated that the defects with 
scaffolds loaded with BMP-2 and undifferentiated hMSCs (rat 73), the empty scaffolds (rat 74), 
and scaffolds with covalently bound RGD (rat 75) had bone area, content, and mineral density 
closest to their corresponding control values (Figure 16A-C). The highest density values were 
evident for rats 74 and 75 (Figure 15). This data does not correspond to the qualitative evaluation 
performed which showed rats 73 and 74 to have the most formation of new bone and bridging of 
the defect area (Figure 13). Since the qualitative evaluation is based on two independent 
observers, and is in fact qualitative, it is feasible to suspect inconsistencies within the analysts’ 
evaluation. To resolve this uncertainty, more observers could be included in the evaluation. 
Despite this one contradiction, the remainder of the qualitative X-ray evaluation is corroborated 
by the DEXA.  
 The data gathered from this phase of the study conflicts with observations made from 
earlier results gathered by Hyeon Joo Kim and David Kaplan from Tufts University. The number 
of rats studied and their corresponding treatment group are in Table 17.  
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Table 17: Treatment groups for previous group of rats studied for critical size femoral defects 
Group# Treatment Animals/group 
1 Empty defect 4 
2 Scaffolds with covalently bound RGD only 3 
3 Defects with tissue-engineered scaffolds covalently bound to RGD (spinner flasks for 4 weeks) 
4 
4 Scaffolds with covalently bound RGD and 
undifferentiated hMSCs 
2 
5 BMP-2 loaded scaffolds 6 
6 Scaffolds loaded with BMP-2 and tissue-engineered hMSCs 
5 
7 BMP-2 loaded scaffold and undifferentiated hMSCs (seeded the day before the surgery) 
4 
 
A qualitative evaluation was performed on this experimental group based on the same 
parameters defined in Table 14 (based on the bridging of the defect and the percentage of bone 
ingrowth). According to the qualitative scorings in the previous phase of the study, empty defects 
and defects with RGD covalently bound to scaffolds had minimal bone ingrowth and trace 
radiodense material over the 8 week time period (Figure 18). When undifferentiated hMSCs 
were added to the RGD scaffolds, there was no significant increase in new bone or bridging of 
the defect. There was, however, gradual bridging of the defect at both the cis and trans cortex 
when tissue engineered hMSCs were added (Figure 18A). At this time point, there was also new 
bone ingrowth that filled more than 50% of the defect (Figure 18B). The results also show that 
there is little difference in new bone and bridging of the defect between the tissue engineered 
scaffolds covalently bound to RGD and any of the BMP-2 loaded groups (Figure 18).  
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Figure 18: Qualitative analyses for bridging of the defect and percentage of bone ingrowth are shown in graphs A 
and B respectively. This was done for empty defects (Group 1), defects with scaffolds with covalently bound RGD 
(Group 2), defects with tissue engineered scaffolds with covalently bound RGD (Group 3), defects with scaffolds 
with covalently bound RGD and undifferentiated hMSCs (Group 4), defects with BMP-2 loaded scaffolds (Group 
5), defects with tissue-engineered BMP-2 loaded scaffolds (Group 6) and defects with BMP-2 loaded scaffolds and 
undifferentiated hMSCs (Group 7). Data are represented as averages (n=2-6). Standard deviations ranged 0-0.98 
(except for Group 4 where n=2). *adopted from Kaplan 
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DEXA scanning results for new bone area, mineral density, and content were also 
performed as was in the current experiment and did support the qualitative scoring obtained in 
Figure 18 (Figure 19). The defects that were loaded with BMP-2 (either alone or with hMSCs) 
and the scaffolds covalently bound RGD and tissue engineered hMSCs showed the highest bone 
ingrowth. These results show that effective osteogenesis occurred when hMSCs were tissue 
engineered ex vivo in spinner flasks for four weeks. In contrast, BMP-2 greatly enhanced healing 
of the defect and the effect induced by BMP-2 was independent of the presence of hMSCs.  
 
Figure 19: DEXA scanning of femoral defect with implants for new bone area (cm2) (black columns), mineral 
density (g/cm2) (white columns) and content (g) (gray columns) for empty defects (Group 1), defects with scaffolds 
with covalently bound RGD (Group 2), defects with scaffolds with covalently bound RGD and tissue engineered 
hMSCs (Group 3), defects with scaffolds with covalently bound RGD and undifferentiated hMSCs (Group 4), 
defects with BMP-2 loaded scaffolds (Group 5), defects with tissue-engineered BMP-2 loaded scaffolds (Group 6) 
and defects with BMP-2 loaded scaffolds and undifferentiated hMSCs (Group 7). Data are represented as averages 
±standard deviation (n=3-6). No standard deviation was included for Group 4, since n=2. *adopted from Kaplan 
 
In the above group, the extent of osteogenesis were markedly higher, according to all 
measured parameters, for defects with RGD covalently bound to scaffolds with tissue engineered 
hMSCs and for all scaffolds loaded with BMP-2. This result is inconsistent with the current data 
collected. Although there was high bone ingrowth for BMP-2 loaded scaffolds with 
undifferentiated hMSCs, growth was also significant for empty defects (rat 74) and RGD 
scaffolds (rat 75) (Figure 15 & 16). These differences could be attributed to, at least in part, to 
the small groups that were used in this phase of the study (n=1, n=0, or n=2). Additionally, rat 76 
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did not show as significant healing as did rat 75, which demonstrates that there is great rat to rat 
variation considering they are both in treatment group 2. 
In the qualitative evaluation and the DEXA scanning, the empty defect resulted in the 
most new bone growth and the most bridging (Figure 13) and area, content, and density values 
similar to the control (Figure 16). It is evident from Figure 14E that the empty defect induced the 
most new bone and obscured most of the cut cortices, although there were still cut edges visible. 
This indicates that osteoconductivity (presence of the scaffold) was sufficient to provide healing. 
The progression and extent of osteogenesis for silk scaffolds has been recognized in biomedical 
application, however it has been with the incorporation of growth factors and/or stem cells 
(Meinel et al., 2004; Sofia et al., 2000).  
Tissue engineering of autologous bone using hMSCs are an obvious source of cells as 
long as they are seeded onto an appropriate substrate. They have the capability to proliferate in 
an undifferentiated state with the appropriate signaling factors. Additionally, they can be easily 
isolated and it has been proposed that the osteogenic pathway is their default lineage (Meinel et 
al., 2004; Banfi et al., 2002). It has been demonstrated that the addition of hMSCs to silk/RGD 
constructs are effective only if tissue engineered ex vivo. RGD is capable of binding the 
intracellular cytoskeleton of the hMSCs to the matrix, however it is not osteoinductive. This is 
true with the previous results. The RGD constructs alone did induce bone formation, however. 
This is attributed to rat to rat variation rather than to the effectiveness of the scaffold itself.  
The effect of BMP-2 on bone formation was dominated by any effect of hMSCs (Figures 
18 & 19). This proves that the addition of BMP-2 was enough to induce osteoinductivity. The 
current experiment could not generate this conclusion because only one specimen had BMP-2 
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incorporated onto the scaffold. However, the data suggested that the formation of new bone was 
significant for the rat with BMP-2 (rat 73) (Figure 15 & 16).   
In regards to the treatment group with the RGD scaffold only, the previous data are in 
accordance with the current results for the qualitative evaluations. However, the current DEXA 
data (Figure 15) shows that there were high bone mineral density, content, and area for rat 75 
and high density for rat 76 which are not evident in Figure 19.  It is evident that the data 
generated in this experiment did not mirror that of the previous one. As mentioned, possibilities 
for these differences may stem from smaller sample sizes and great rat to rat variation. It can also 
be speculated that the fabrication method of the scaffolds resulted in significant matrix 
heterogeneity. This is likely due to the evaporation of the solvent (Nazarov et al., 2003). As a 
result there can also be scaffold to scaffold variation, which will ultimately change the healing 
process and new bone formation independent of the growth factors or stem cells. Research has 
suggested that the silk scaffold geometry and morphology predetermines the geometry of the 
new engineered bone. It can be speculated that the morphology of the certain scaffolds imparted 
diffusional limitations which restricted the formation of compact and contiguous bone.  
Another study conducted at Tufts University by Kim et al. described a new process to 
form silk scaffolds. This aqueous-derived scaffold avoided the use of organic solvents and 
resulted in a more uniform morphology compared to that of the HFIP-derived silk scaffolds used 
in this experiment. The more homogenous a scaffold is throughout will provide improved 
mechanical properties of the matrix. This is because stress is concentrated at pore interfaces and 
the lack of uniformity typically causes deformation at lower stresses (Harris et al., 1998). 
In summary, tissue engineered bone was created for defects that were empty and defects 
with scaffolds loaded with BMP-2. This was corroborated with DEXA scanning. DEXA, 
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however, also demonstrated that new bone was formed for the defects with silk/RGD constructs 
only (rat 75 but not rat 76). This data differs from the results gathered from the previous group 
that was analyzed. Such differences could be explained by the small experimental groups, rat to 
rat variation, and scaffold to scaffold variation that comes from the fabrication method.   
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VIII. Conclusions 
 Porous, three-dimensional silk fibroin matrices were prepared from the addition of HFIP 
and methanol and fabricated by a method of salt leaching. Combinations of RGD +/- hMSCs or 
BMP-2 +/- hMSCs were added to the silk scaffolds to determine which combination induced 
tissue engineered bone. According to qualitative analysis, the in vivo study demonstrated that the 
defects with the empty scaffolds (rat 74) and scaffolds loaded with BMP-2 and undifferentiated 
hMSCs (rat 73) induced formation of new bone and bridged the defect over an eight week time 
period. The DEXA analysis showed similar results except the defects with silk/RGD constructs 
only (rat 75) had similar bone ingrowth to rats 73 and 74.  
  The distinguishing features of silk fibroin made it an appealing scaffold biomaterial for 
the demanding and unique environment of bone. The protein provides mechanical integrity that 
match the repair site and also allows for control of the properties through various processing 
methods. Additionally, silk is biocompatible, resorbable, has a diverse surface chemistry, is 
highly organized, and has a beneficial overall tailorability that is unattainable with other 
biomaterials used in today’s technology. 
 Although there are some contradictory results within the data, when the mechanical 
features of silk are considered in addition to biocompatibility, biodegradability, and versatility in 
chemistry, these silk biomaterials offer new and important options in designing three-
dimensional matrices. Furthermore, when coupled with the processing and fabrication options 
available for silks, the biomaterial can be improved and generate a range of materials and 
properties.  
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IX. Future Recommendations 
 Further analysis is needed to confirm the osteogenesis of the scaffold: 1) Investigate 
tissue reaction to the silk constructs by histology tests (including necrosis, inflammation, giant 
cells, macrophages, and scarring); 2) Micro-computer tomography; 3) Measure degradation rate 
of the product as well as mechanical properties (Young’s modulus and compression). 
 In order to better evaluate osseointegration of the tissue engineered construct, a 3-D 
evaluation technique could be employed called micro-computed tomography. This non-
destructive method could characterize the regeneration of bone tissue at the micron scale. Such a 
technique would also help to further understand the process of tissue engineered bone ingrowth. 
This, in turn, could potentially optimize scaffold design since there is still a great deal unknown 
about structural and transport properties during tissue ingrowth. This type of analysis could 
complement the type of analysis techniques performed and answer questions that would 
otherwise be unanswered. For example, the technique could establish if the bone within the 
scaffold is interacting with the native bone and determine the direction of mineralization. This is 
important because with the 2-D analysis that was conducted in the current experiment, it is 
difficult to determine whether the observed growth is from the host femur bone or rather 
outgrowth for the silk construct.  
 During experimental process, there were a few points observed that may be conducted 
slightly different during future experiments in order to improve the outcome of the results.  
When the X-rays were taken of the rats’ femurs, they were not all taken in the same position.  
This could have obscured the qualitative analysis in that the new bone growth was not seen 
clearly.  When future experiments are conducted, they might try positioning all of the legs in the 
exact same angle, possibly through building an apparatus to hold the femur in place.   
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 Additionally, the constructs should be enhanced based on the knowledge obtained from 
the experiment to more fully meet the structural, mechanical, and physiochemical properties of 
bone scaffolds. 
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Appendices 
Appendix A 
Methods of Analysis 
 Dual-Energy X-ray Absorptiometry  
In order to measure bone density, scientists often look to an enhanced form of x-ray 
technology called dual-energy x-ray absorptiometry (DEXA). DEXA has become the standard 
for measuring bone mineral density (BMD) (American College of Radiology & Radiological 
Society of North America, 2003).  The procedure is a fast and painless method for measuring if 
bone loss or formation is occurring.  
The DEXA procedure takes between 10 and 30 minutes to perform.  The device transfers 
a visible beam of low-density x-rays through the bone by means of two energy streams 
(American College of Radiology & Radiological Society of North America, 2003).   It relies on 
two distinct energy peaks: one peak is absorbed mainly by soft tissue and the other by bone. The 
soft tissue amount can be subtracted from the total, and what remains is a patient's bone mineral 
density (American College of Radiology & Radiological Society of North America, 2003).  The 
data then is displayed on a computer screen in order to make a diagnosis.   
 Computed Tomography (CT) Scan  
A micro Computed Tomography (CT) scan, particularly the GE eXplore RS model, is 
also utilized in order to measure the success of biomaterials.  “It is an ideal instrument for 
biomedical research laboratories to non-destructively acquire 3-D images of both in vivo and in 
vitro specimens” (GE Healthcare, 2004).  The GE eXplore RS is used particularly for small 
laboratory animals such as rats or mice.  It is able to capture whole body images at 45 or 90 µm 
 90 
and in vitro specimens at 27 µm (GE Healthcare, 2004).  GE eXplore RS CT scans have 
Conebeam CT technology, enabling the total volume of a sample to be imaged in one rotation, 
instead of having to measure slice by slice.   
 Radiographs 
 This technique is used to follow healing after bone defects are made.  Usually the wound 
is followed radiographically every 2 or 4 weeks.  Such post-operative procedures provide a 
means to qualitatively monitor the level of bone regeneration and implant resorption.  However, 
there are methods in which the radiographs can be digitized to present quantitative data.   
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Appendix B 
Radiographs 
Rat #69: 
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Appendix C 
DEXA Scanning of Defected Area 
Rat #69: 
Defect Area 
Region Area (cm2) Bone mineral 
content (g) 
Bone mineral density 
(g/cm2) 
Global  0.2143 0.0596 0.2780 
R1 0.0047 0.005 0.1056 
R2 0.0056 0.0006 0.1138 
R3 0.0000 0.0000 0.0000 
 
Rat #71: 
Defect Area 
Region Area (cm2) Bone mineral 
content (g) 
Bone mineral density 
(g/cm2) 
Global  0.1565 0.0484 0.3090 
R1 0.0000 0.0000 0.0000 
R2 0.0000 0.0000 0.0000 
R3 0.0000 0.0000 0.0000 
 
Rat #72: 
Defect Area 
Region Area (cm2) Bone mineral 
content (g) 
Bone mineral density 
(g/cm2) 
Global  0.1593 0.0431 0.2704 
R1 0.0093 0.0013 0.1355 
R2 0.0093 0.0013 0.1355 
R3 0.0000 0.0000 0.0000 
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Rat #73: 
Defect Area 
Region Area (cm2) Bone mineral 
content (g) 
Bone mineral density 
(g/cm2) 
Global  0.4081 0.1137 0.2786 
R1 0.1360 0.0224 0.1647 
R2 0.1854 0.0298 0.1608 
R3 0.0811 0.0099 0.1222 
 
Rat #74: 
Defect Area 
Region Area (cm2) Bone mineral 
content (g) 
Bone mineral density 
(g/cm2) 
Global  0.3317 0.0819 0.2470 
R1 0.1258 0.0250 0.1985 
R2 0.1277 0.0252 0.1970 
R3 0.0457 0.0084 0.1834 
 
Rat #75: 
Defect Area 
Region Area (cm2) Bone mineral 
content (g) 
Bone mineral density 
(g/cm2) 
Global  0.3942 0.1187 0.3012 
R1 0.0801 0.0189 0.2363 
R2 0.1323 0.0296 0.2236 
R3 0.0112 0.0020 0.1765 
 
Rat #76: 
Defect Area 
Region Area (cm2) Bone mineral 
content (g) 
Bone mineral density 
(g/cm2) 
Global  0.2357 0.0567 0.2403 
R1 0.0307 0.0055 0.1782 
R2 0.0345 0.0058 0.0169 
R3 0.0000 0.0000 0.0000 
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Appendix D 
DEXA Scanning of Control Area 
Rat #69: 
Control Area 
Region Area (cm2) Bone mineral 
content (g) 
Bone mineral density 
(g/cm2) 
Global  0.4137 0.0913 0.2206 
R1 0.2069 0.0440 0.2128 
R2 0.2078 0.0446 0.2144 
R3 0.2059 0.0436 0.2117 
 
Rat #71: 
Control Area 
Region Area (cm2) Bone mineral 
content (g) 
Bone mineral density 
(g/cm2) 
Global  0.3839 0.0811 0.2138 
R1 0.1901 0.0406 0.2137 
R2 0.1892 0.0394 0.2085 
R3 0.1901 0.0414 0.2177 
 
Rat #72: 
Control Area 
Region Area (cm2) Bone mineral 
content (g) 
Bone mineral density 
(g/cm2) 
Global  0.4072 0.0886 0.2177 
R1 0.1975 0.0427 0.2159 
R2 0.1966 0.0414 0.2105 
R3 0.1975 0.0431 0.2182 
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Rat #73: 
Control Area 
Region Area (cm2) Bone mineral 
content (g) 
Bone mineral density 
(g/cm2) 
Global  0.4147 0.0870 0.2099 
R1 0.2003 0.0397 0.1979 
R2 0.2013 0.0397 0.1973 
R3 0.2013 0.0400 0.1990 
 
Rat #74: 
Control Area 
Region Area (cm2) Bone mineral 
content (g) 
Bone mineral density 
(g/cm2) 
Global  0.3355 0.0798 0.2378 
R1 0.1696 0.0396 0.2337 
R2 0.1705 0.0412 0.2416 
R3 0.1668 0.0386 0.2316 
 
Rat #75: 
Control Area 
Region Area (cm2) Bone mineral 
content (g) 
Bone mineral density 
(g/cm2) 
Global  0.5106 0.1293 0.2532 
R1 0.1659 0.0409 0.2467 
R2 0.1649 0.0406 0.2460 
R3 0.1668 0.0411 0.2464 
 
Rat #76: 
Control Area 
Region Area (cm2) Bone mineral 
content (g) 
Bone mineral density 
(g/cm2) 
Global  0.4137 0.0714 0.1727 
R1 0.1985 0.0334 0.1685 
R2 0.1966 0.0332 0.1689 
R3 0.2050 0.0346 0.1688 
 
